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INTRODUCTION 
Hog cholera (HC) was first recognized in the United States in 1833. 
However, it was not until 1903 that its viral etiology was discovered. 
Since that time there has been a definite need for a readily acceptable 
.!.!l vitro diagnostic test. Although a presumptive diagnosis can often be 
made on clinical signs and lesions, these are occasionally too indefinite 
to be of value. Additional confusion arises because the lesions of 
several other swine diseases may closely resemble those of HC. Moreover, 
when HC is caused by a virus of relatively low virulence, the signs and 
lesions are often atypical. These difficulties emphasize the desirability 
for laboratory confirmation of all tentative clinical diagnoses. 
Two events have added considerable impetus to investigations of HC 
diagnostic tests. In 1957, African swine fever (ASF) spread from Africa 
to Southern Europe. Although ASF is presently exotic to the United 
States, its spread increases the threat of its introduction here. Since 
the lesions of ASF closely resemble those of HC, a method for a rapid 
differential diagnosis is imperative. In 1962, a RC-eradication program 
was implemented in the United States. A reliable means of diagnosis is 
essential for the program to be carried out most effectively. 
Numerous in vitro tests have been proposed for the diagnosis of HC; 
however, it is apparent from reviewing published reports that these 
techniques are either inherently complex or have been subjected to 
criticism in r egard to their reliability or have not been sufficiently 
investigated as to their practical diagnostic efficacy. 
.... 
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Since the fluorescent antibody technique (FAT) is in the latter 
category above, it was obvious that a critical evaluation of the test 
was required before recommendations could be made for its routine use 
to confirm clinical diagnoses of HC. Consequently, the following study 
was initiated to determine the reliability of FAT and the technical 
considerations necessary for its optimwn performance when tissue . samples 
from suspected naturally-occurring cases of RC are submitted to the 
diagnostic laboratory. 
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REVIEW OF LITERATURE 
Three general types of .!!l. vitro tests, which depend on the identifi-
cation of HCV or related antigens, ' are presently being used in various 
laboratories to confirm clinical diagnoses of naturally-occurring HC. 
These are agar gel diffusion (AGD), viral interaction (VI), and the FAT. 
Agar gel diffusion is a serological test in which antigen and antibody 
are initially separated by agar gel. The reactants subsequently diffuse 
toward one another. At a place where their optimum relative concentration 
is reached, a visible precipitate is formed. The AGD method of Ouchterlony 
(1) was first used to identify HC-viral antigens by Molnar (2). He 
observed that precipitation lines were formed when tissues from HCV-
infected swine were allowed to react with RC-immune serum; whereas, lines 
were not formed when tissues from uninfected swine were reacted against 
RC-immune serum. Subsequently, numerous other investigators (3-16) 
generally concurred with Molnar's findings; however, alterations in the 
technique were proposed and there was disagreement in some instances as 
to the most satisfactory tissue to be used for the test. In contrast, 
Janowski and Truszczynski (17), Janowski (18), and Pirtle (19) questioned 
the reliability of AGD. They observed that precipitation occurred when 
either RCV-infected or uninfected tissues were allowed to react with 
either RC-immune or nonimmune serum. Moreover, Pirtle (19) reported that 
precipitation lines were formed more frequently when uninfected tissues 
were allowed to react with either RC-immune or nonimmune serum than when 
HCV-infected tissues were reacted with the same sera. Based on the above 
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evidence, it was his opinion that AGD was not specific and therefore 
unsatisfactory as a diagnostic test. Pirtle (20,21) suggested that the 
nonspecific reactions which he observed could have been caused by tissue 
proteins which were not associated with HCV infection and that AGD might 
find application if a specific antigen could be obtained. As a conse-
quence, he isolated and semi-purified a HCV-associated soluble antigen 
produced in infected swine kidney cell cultures. He was then able to 
employ this soluble antigen in AGD to identify homologous antibody in 
sera of swine previously exposed to HCV. · When the semi-purified antigen 
was used, nonspecific reactions were not observed. A comprehensive review 
of the application of AGD to HC diagnosis has been published (22). 
Many viruses have a characteristic cytopathic effect (CPE) in cell 
cultures. The presence of a particular virus can be confirmed by neutral-
ization with homologous immune serum. Unfortunately, HCV, with one 
exception (23), is not cytopathogenic. Therefore, several indirect 
methods involving- a second, i.e., an indicator virus, have been investi-
gated for the detection of HCV infected cell cultures, and thus HCV itself. 
Viral interaction is evidenced by the alteration of a characteristic 
cellular response to infection with one virus caused by prior infection 
of the cell with another virus. 
An ingenious technique was developed by Kumagai ~.!!.!.· (24). They 
found that the CPE of the Miyadera strain of Newcastle disease virus 
(NDV) on swine testicular cell cultures was exalted, in regard to the 
time it was first observed, if the cells were already infected with HCV. 
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The technique has been called the exaltation of Newcastle disease virus 
(END) method. Since its inception, the END method has been thoroughly 
investigated and, notwithstanding some minor technical difficulties that 
might be initially encountered in its application, has been proven 
reliable for the detection of HCV and homologous antibody (25-31). 
Matumoto ~.!!.· (26) applied the END method to the diagnosis of HC. 
Thirteen of 17 naturally occurring cases of HC, diagnosed by clinical and 
histopathologic examinations, were confirmed by the END method. Two 
additional cases were confirmed by a 2-step procedure wherein tissue 
suspensions are first inoculated onto swine spleen cell cultures. After 
allowing HCV to propagate in the cell cultures, the growth med~um. is 
examined by the END method. Hog cholera virus was not identified from 
tissues from the remaining 2 cases even though l of these was subsequently 
confirmed by swine inoculation. 
Loan (32,33) suggested certain alterations in the basic technique 
for conducting the END method. The application of these changes would 
bo·t:'h simplify the method and increase its sensitivity 25-100 fold. 
The importance of the strain of NOV employed as the indicator virus 
and the kind of cell cultures used is emphasized by the research 
conducted by Nishimura~.!!· (34). When BCV-infected swine kidney cell 
cultures were superinfected with the Sato strain of NDV, a different 
phenomenon was observed. The CPE of the Sato strain of NDV was not 
exalted, but suppressed; however, the yield of NDV associated hemagglutinin 
from dually infected cells was increased. 
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In addition to NDV, several other viruses such as Teschen disease 
virus (35), influenza virus (36), bovine viral diarrhea virus (37), 
poliovirus, and foot-and-mouth disease virus (38,39) have been used as 
indicators of HCV-infected cell cultures. 
The FAT is a serological test wherein antibody is conjugated with 
a fluorescent dye. After allowing antigen and antibody to form a . stable 
union with each other, the antigen is indirectly identified by 
microscopically examining the specimen with ultraviolet or near-ultraviolet 
light. An area of concentrated fluorescence indicates the presence of 
antigen. 
This technique, developed by Coons ~.el· (40,41), was first described 
in 1941 and has since been successfully employed for the diagnosis of 
several viral diseases (42). Only recently, however, has the FAT been 
successfully used to identify HC-viral antigens. Two approaches have 
been made to apply this technique to the diagnosis of HC. Tissues from 
swine suspected o~ having HC have been examined directly for the presence 
of HCV-infected cells. A second approach has been to inoculate blood, 
serum, urine or tissue suspensions onto cell cultures and after an 
appropriate period of time to allow intracellular viral replication to 
occur, to examine the cultures for the presence of infected cells. This 
latter approach will subsequently be referred to as the fluorescent 
antibody-tissue culture test (FATCT) to distinguish it from the former 
which will be designated as the direct fluorescent antibody test (DFAT). 
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Sirbu .!U..!l• (43) used the DFAT to identify RC-viral antigens in 
· cells of impression smears prepared from lymph nodes of HCV-inf ected 
swine. Infected cells were observed in lymph node impression smears of 
24 of 27 (91.1%) experimentally infected swine and of 5 of 5 naturally 
infected swine. 
Stair .!U..!l· (44) and Aiken .!U_ al. (45,46) reported that the DFAT 
could be used in conjunction with either tissue impression smears or 
tissue sections (cryostat technique) to identify HCV-infected cells. 
Results obtained with both methods compared favorably under most 
conditions. Limited experiments indicated that antigens associated with 
attenuated HCV could only be identified in tonsillar tissue. _In addition, 
antigens associated with virulent HCV were identified in tonsillar tissue 
earlier after HCV infection than in other tissues. Therefore, tonsils 
were considered the tissue of choice. Since impression smears prepared 
from tonsils were not consistently satisfactory, the cryostat technique 
was suggested as the method of choice. 
Solarzano (47) successfully applied the FATCT to identify cell 
cultures infected with HCV present in urine, blood and serum from HCV-
infected swine. Mengeling .!U.!l· (48,49) used the FATCT to demonstrate 
HCV-virus infected cells of a chronically infected cell line and cells 
infected with HCV isolated from blood and spleen from swine affected with 
HC. Robertson~ al. (50) investigated the FATCT and reported that it 
appeared to be a highly reliable method for the diagnosis of HC. 
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Karasszon and Bodon (51) found the indirect FATCT suitable for the 
identification of HC-viral antigens. The indirect method is a 2-step 
procedure. It requires labeled (fluorescent) antibody prepared for 
globulin of the species used to produce antibody for the antigen in 
question. In the first step, antigen and its homologous unlabeled anti-
·~. 
body are allowed to react. In the second step, labeled anti-globulin is 
added. Consequently, the unlabeled antibody functions as antibody in 
the first reaction and antigen in the second reaction. Korasszon and 
Bodon used unlabeled rabbit anti-hog cholera sera and fluorescein labeled 
goat anti-rabbit globulin. 
It would be advantageous if the reliability of the preceding 3 general 
types of in vitro tests could be compared , but such a comparison is 
difficult for several reasons. For example, Darbyshire (22) found that 
36% of pancreases from HCV-infected pigs gave positive AGD reactions, 
whereas no reactions were observed with tissues from healthy pigs or with 
tissues from 1,032 -pigs affected with a variety of other diseases. 
Therefore, one would conclude that AGD is not highl y sensitive but 
nevertheless reliable from the standpoint that no false positive reactions 
were observed. On the other hand, Pirtle (19) obtained more reactions 
with pancreases from healthy swine than with those from RC-affected swine . 
Moreover, neither the FAT nor VI have been sufficiently investigated in 
relation to HC diagnosis to confidently state their reliability , but it is 
significant that, as yet, no false positive reactions have been reported 
for either type of tes t. 
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Several other in vitro tests have been proposed for the identifi-
cation of HG-viral antigens and homologous antibodies. Segre (52 , S3) 
coated both resins and erythrocytes with HC antibody . Agglutination of 
the antibody-coated particles occurred in the presence of viral antigen. 
Segre (S4) also demonstrated that HC virus could be identified by its 
CPE on cell cultures incubated under increased oxygen pressure. Boulanger · 
~~· (SS) were able to detect RC-viral antigens by complement fixation . 
Hog cholera antibody has been identified by conglutination complement 
adsorption, Engelhard and Millian (S6), and Millian and Engelhard (S7), 
and by serum neutralization, Coggins and Baker (S8). None of these tests 
have as yet received general application for RC diagnosis. However , the 
identification of RC antibody may become increasingly important in the HC 
eradication program in the United States, particularly in epidemiology. 
Three procedures have been developed for demonstrating RCV-infected 
tissues based on biochemical alterations of the tissues. These are the 
amylase and hemolytic tests of Taylor (S9) and the chemical color test of 
Goncharov ~al. (60). Results of investigations by Gray~~· (61) 
indicate that neither the amylase nor the hemolytic test is sufficiently 
reliable for HC diagnosis. 
Histopathological changes in the brain and the occurrence of a 
leukopenia in swine affected with HC have been used as diagnostic aids. 
Neither can be considered as definitive proof of HC, but in practice 
both have been generally reliable, particularly when several swine are 
examined. The application of these methods has been reviewed by Dunne (62) . 
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GENERAL APPROACH TO THE EVALUATION OF THE 
FLUORESCENT ANTIBODY-TISSUE CULTURE TEST 
Tissues from suspected naturally occurring cases of HC were examined 
by the FATCT. Results thus obtained were compared to those obtained by 
the inoculation of RC-susceptible swine with a portion of the same tissues. 
~ 
Although swine inoculation is too expensive for routine use 9 it is the most 
reliable method for RC diagnosis and was therefore used to determine the 
reliability of the FATCT. The inoculation of RC-susceptible swine with 
field isolates of HCV also allowed for the determination of the relative 
virulence of these isolates. 
For the purpose of clarity. the methods and results of the FATCT and 
swine inoculation are first presented separately and then the results of 
each are compared. 
11 
-... 
PART I. FLUORESCENT ANTIBODY-TISSUE CULTURE TEST 
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MATERIALS AND METHODS 
Preparation of Fluorescent Antibody 
Swine anti-hog cholera sertml (anti-HC serum) 
Three anti-HC sera were used to prepare fluorescent antibody. Anti-
HC serum 9197 was produced in a farm-raised pig of mixed breeding. 
Initially, the pig was vaccinated on the farm of origin with crystal 
violet hog cholera vaccine. Eight months later it was purchased and 
brought to the National Animal Disease Laboratory (NADL) where its 
immunity was challenged by subcutaneously injecting 2 ml of swine blood 
containing the virulent Ames strain of HCV* (Ames HCV). Following a 
slight reaction to challenge, a transient leukopenia and temperature 
rise, the pig recovered and 1 month later was injected intravenously 
with 875 ml of swine blood containing Ames HCV. Exsanguination was per-
formed 2 weeks later. The whole blood was allowed to clot and the serum 
obtained was clarified by centrifugation for 30 min at 2,000 x g**• 
bacteriologically sterilized by filtration and stored at 4 c. 
A conunercial anti-HC serum was made available by Dr. C. E. Phillips.*** 
The serum had been specially prepared from clotted whole blood rather 
*Lethal strain of HCV maintained at the NADL by serial passage in 
swine. 
**All centrifugations unless otherwise specified were made with an 
International PR-2 refrigerated centrifuge. 
***Dr. C. E. Phillips, NADL, Ames, Iowa. 
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than the usual commercial method. of . mechanical defibrination, followed 
by the addition of bean extract and NaCl. Swine anti-HC serum 7185 was 
kindly supplied by Dr. J. P. Torrey.* 
Serum fractionation 
Globulins, primarily gannna, were obtained from swine serum by the 
dropwise addition of 1/2 volume of a saturated solution of ammonium 
sulfate** at room temperature . to 1 volume of swine serum at 4 c. During 
the addition of anmonium sulfate the serum was kept chilled by an ice 
bath and was constantiy agitated with an electric stirrer. Stirring was 
continued for 10 min after ammonium sulfate had been added. Globulins 
were then sedimented by centrifugation for 15 min at 2000 x g. Supernatant 
fluid was carefully decanted from the sedimented globulins and the 
precipitate restored to the original serum volume by the addition of cold 
distilled water. 
The fractionation procedure was repeated two additional times, with 
the exception that in the final step sufficient distilled water was added 
to bring the solution of globulins to only 1/2 the original serum volume. 
Redissolved globulins were freed of residual anunonium sulfate by 
dialysis for 1 hr at 4 C against 0.85% NaCl (100 volumes saline/volume 
globulin solution), followed by 2 additional 2 hr dialyses against fresh 
saline. Fluid outside the dialysis tubing was constantly agitated with an 
*Dr. J. P. Torrey, NADL, Ames, Iowa. 
**542 grams ammonium sulfate/liter. 
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electric stirrer. Insoluble material present after dialysis was removed 
by centrifugation at 2000 x g for 15 min. 
Protein determination 
Protein concentrations were determined spectrophotometrically by the 
biuret method (63) at a wave-length of 540 mP utilizing a Coleman Jr. 
spectrophotometer.* Two ml of a 1:6 dilution of a globulin solution in 
0.85% NaCl was mixed with 8 ml of biuret reagent and incubated at room 
temperature for 30 min before determining its optical density. A blank 
was prepared with 2 ml 0.85% NaCl and 8 ml of biuret reagent. The optical 
density of the unknown was compared to that of known quantities of purified 
bovine albumin** for which a standard curve had p~eviously been prepared.*** 
Conjugation 
The protein concentration of the globulin solution was adjusted to 
10 mg/ml by dilution with 0. 85% NaCl. Five-hundredths mg of fluorescein 
isothiocyanate (FI TC)****/mg of protein was dissolved in a sufficient 
volume of carbonate-bicarbonate buffer, pH 9***** to comprise 10% of the 
combined volume of the reactants. The FITC solution was slowly added to 
the globulin solution at 4 c. During this procedure the globulin solution 
*Coleman Instruments, Inc., Maywood, Ill. 
**Armour Pharmaceutical Co., Kankakee, I llinois. 
***Prepared by Dr. E. c. Pirtle, NADL, Ames, Iowa. 
****Nutritional Biochemicals Co., Cleveland, Ohio. 
*****See Appendix A. 
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was kept chilled by an ice bath and continuous l y agitated with an electric 
stirrer. The mixture was then reacted overnight (approximately 16 hrs) at 
4 C with constant stirring (64). 
Gel filtration 
Separation of free FITC from the FITC-protein complex (labeled 
antibody) was accomplished by gravity passage of the mixture through a 
Sephadex gel* column (65). The sephadex (G-25, coarse) had previously 
been washed with phosphate buffered saline pH 7.2-7.4 (PBS) and was 
maintained as a stock preparation 1:4 in PBS. A poured column of Sephadex 
measuring approximately 2 by 20 cm was used for separation of 20-30 ml 
volumes, with correspondingly larger columns employed for greater volumes. 
After the gel had settled in the col\.lllln, the fluid level was adjusted to 
its surface and the sample carefully added. As t he last of the sample 
entered the gel, it was followed by a sufficient vollmle of PBS to elute 
the FITC-protein complex, leaving the unconjugated FITC in the upper 
portion of the column. Progress of the labeled protein through the 
colunm was easily followed by its yellow color. 
Sorption 
Elements of the label ed antibody preparation responsible for non-
specific staining were essentially removed by "sorption" with 20-30 mg 
of rabbit liver powder (RLP)**/mg of protein. To determine the total 
*Pharmacia, Ltd., Uppsala , Sweden. 
**See Appendix A. 
·.;. 
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quantity of RLP required, it was assumed that the preparation contained 
the same amount of protein as had been calculated prior to the conjugation 
procedure. A slurry was prepared by adding 2.5 ml of PBS to each gm of 
RLP. Phosphate buffered saline was added for its buffering capacity and 
to hydrate the powder, thus preventing a marked reduction in the volume 
of labeled antibody. Sorption was performed overnight with constant .;. 
stirring at 4 c. 
The bulk of the RLP was removed from the labeled antibody solution 
by centrifugation at 2000 x g for 30 min. · Remaining RLP was sedimented 
by centrifugation at 78,000 x g for 1 hr using a #30 rotor in a Spinco 
Model L preparative ultracentrifuge.* 
Standardization 
A titration of each preparation of fluorescent antibody was performed 
to determine an appropriate dilution for routine use. 
Cultures of PK-15 swine kidney line cells** grown on coverslips in 
Leighton tubes were each infected with approximately 500 tissue culture 
infecting doses of HCV and incubated for 24 hrs to allow circumscribed 
areas of infection (plaques) to develop from each initially infected cell. 
Plaques surrounded by uninfected cells provided the test system whereby 
the degree of nonspecific and specific staining could be graded and 
compared at various dilutions of fluorescent antibody. 
*Beckman Instruments, Inc., Spinco Division, Palo Alto, California. 
**The original culture of these cells was kindly supplied by Cutter 
Laboratories, Berkeley, California. 
17 
The working dilution was selected in the following manner. Undiluted 
fluorescent antibody gave bright specific staining and a variable degree 
of nonspecificity, usually more than desired. As progressive twofold 
dilutions were made, the intensity of specific staining decreased slowly, 
whereas nonspecificity decreased rapidly. Therefore, a dilution was 
selected that allowed bright specific staining and a minimum of nonspecific
4
. 
staining. Usually a 1:8 to 1:16 dilution was satisfactory. 
Storage 
Fluorescent antibody was diluted with PBS to the working dilution and 
Merthiolate* was added to a final concentration of 1:10,000. Aliquots were 
distributed to screw-cap vials and maintained at -60 c in a mechanical 
freezer** 1.llltil needed. 
If an entire vial of fluorescent antibody was not used on the day it 
was thawed, it was maintained at 4 C and used as required. The fluorescent 
antibody was discarded if a precipitate formed during storage at 4 c. 
Tissue (Cell) Cultures 
The PK-15 swine kidney cell line was propagated and maintained by 
twice weekly subculture in milk dilution bottles and was nourished with 
Earle's balanced salt solution .supplemented with 0.5% lactalbumin 
*Eli Lilly Co., Indianapolis, Indiana. 
**Revco, Inc., Deerfield, Michigan. 
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hydrolysate and 10% serum from specific pathogen free (SPF-1)* or second 
generation SPF (SPF-2)** swine. Penicillin and streptomycin were added 
to final concentrations of 100 units/ml and 100 ug/ml respectively. 
Twice weekly, PK-15 cells were implanted on coverslips contained in 
Leighton tubes to provide a continuous supply of young cultures for the 
FATCT. Cultures were used for the FATCT during an interval of 3-4 -days 
after the cell layer had become confluent. 
Procurement and Processing of Field Samples 
Spleen and blood samples from swine herds in which HC had been 
tentatively diagnosed were submitted by either veterinary practitioners, 
or field representatives of the Animal Health Division, Agricultural 
Research Service, United States Department of Agriculture, or the Iowa 
State University Veterinary Diagnostic Laboratory. All samples received 
on the same day and from the same source from a suspected case of RC 
were referred to coilectively as a specimen. Specimens were identified 
by number and were numbered in the sequence in which they were received 
at the NADL. Usually, only 1 specimen was submitted from each case and 
therefore the specimen and case number correspond. Occasionally more 
than 1 specimen was submitted. In these instances, the case number 
corresponds to a combination of the specimen numbers, e.g., specimens 
*Hysterectomy-derived, colostrum-deprived swine raised in an environ-
ment in which there was a minimal chance of exposure to swine pathogens. 
**First generation progeny from SPF-1 swine. 
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18, 19 and 20, case number 18-19-20. Field isolates of HCV were given 
the same number as the respective case from which they were obtained. 
Each blood sample was transferred from the container in which it 
was received to a sterile centrifuge tube and centrifuged for 15 min at 
2000 x g. The clear serum or plasma was used as inoculum for both cell 
cultures and swine.* 
Each spleen was freed of omentum and approximately 10 gm of splenic 
tissue was then transferred to a chilled blender jar containing 25-30 ml 
of cold cell culture mediwn (CCM). The type of culture medium used in 
this step was identical to that employed for propagating the PK-15 swine 
kidney cell line. The spleen-CCM mixture was blended for approximately 
5 min. The mixture was then transferred to a sterile centrifuge tube 
and centrifuged for 15 min at 2000 x g. Clarified supernatant fluid was 
used for both cell culture and swine inoculation. 
The portion of each sample which was not used for inoculum or in 
the preparation of inoculum was stored at -60 C for future reference. 
Inoculation of Cell Cultures 
Cell culture medium was decanted from an appropriate number of PK-15 
cell cultures on coverslips in Leighton tubes. Each of 2 cell cultures 
was inoculated with 2 ml** of test material prepared from each field sample. 
*See PART II. SWINE I NOCULATION TEST. 
**If a sufficient amount of the field sample was available to prepare 
this volume of inoculum. 
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After 1 hr's incubation at 37 C to allow adsorption of HCV to occur, the 
test material was decanted. Cell cultures were carefully washed several 
times with CCM to remove any remaining debris. After the addition of 1 
ml of fresh CCM to each culture, they were incubated at 37 c. 
Staining and Examination of Cell Cultures 
After 16-24 hrs' incubation, 1 of the 2 cell cultures inoculated 
with each sample was processed for fluorescent microscopy as follows: 
coverslip cultures were washed in PBS, dried, fixed in acetone at room 
temperature for approximately 10 min, dried, placed in a humidity chamber 
and stained with fluorescent antibody for a minimum of 10 min at 37 c, 
washed in PBS, dried and mounted in PBS-glycerine _(1:1) on a microscope 
slide. Examinations were made using a Leitz ortholux microscope equipped 
with a darkfield condenser, BG-12 primary filter, OG-1 barrier filter and 
an Osram HB0-200 mercury vapor burner. 
If 1 or more of the cell ·cultures inoculated with samples of a 
particular specimen was FATCT positive at the 16-24 hr examination, a 
diagnosis of HC was recorded and the duplicate cultures were discarded . 
If none of the cultures inoculated with samples of a particular 
specimen were FATCT positive at the 16-24 hr examination, the duplicate 
culture inoculated with each sample was examined after an additional 24 
hrs ' incubation. 
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Estimation of the Virus Content of Field Samples 
Early in this study, samples were recorded only as FATCT positive or 
negative , However, starting with the eighty-eighth field specimen, an 
estimation was made of the HCV titer of each FATCT positive sample, The 
titer was detennined either by counting fluorescent foci of infection 
(plaques) or by estimating the % of infected cells of the total number 0£ 
cells of the culture infected with the respective sample, When the virus 
titer was 103 or less, plaque· counts were made, It had previously been 
demonstrated, that within 16-24 hrs after infection, there was only a 
minimal amount of virus spread from the initial foci of infection, If 
there were few plaques, the entire cell culture was examined, If the 
plaques were numerous, i.e., 100-1000, 20% of the culture was examined 
and the resulting plaque count multiplied by 5. The counting of plaques 
became increasingly difficult as titers approached 103• In fact, when 
titers were much greater than 103 , plaque counting was impossible since 
plaques were so numerous that they formed confluent areas of infection. 
Titers greater than 103 were therefore estimated by the % infection 
method , i,e. , the% of infected cells of the total number of cells of a 
culture, It was experimentally demonstrated that 50% infection of a 
culture, infected 16-24 hrs previously, corresponded to a virus titer of 
4 approximately 10 • Consequently more than 50% infection corresponded to 
4 a titer greater than 10 (Figs. 1, 2, 3 and 4). 
The method of titration just described was employed primarily because 
of its simplicity. The same cell culture used to determine if a sample 
Fig. 1. Plaque, 24 hrs after cell culture infection 
Fig. 2. Plaque, 24 hrs after cell culture infection 
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.... 
Fig. 3. Approximately 507. cell culture infection as evidenced by 
fluorescence 
Fig. 4. Complete cell culture infection as evidenced by fluorescence 
25 
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contained HCV, was also used for titration. The method was not extremely 
precise and therefore an exact titer was not assigned to any individual 
sample. Rather, samples were placed in l of 5 broad categories as follows: 
(1) 1-10 plaques, (2) 11-100 plaques, (3) 101-1000 plaques, (4) 1001 
plaques - 50% cell culture infection, and (5) greater than 50% cell culture 
infection. For purposes of comparison, samples were given either an 
average titer, e.g., each sample in category 1 was assigned a titer of 5 
infectious units, or were given the number of their category, e. g., each 
sample in category 1 -was assigned the value of 1. 
A few additional statements of explanation are necessary for the 
former method of comparison. Category 5, as defined, has no . upper limit. 
4 
Samples placed in this category simply had HCV titers which exceeded 10 • 
Based on prior experience with HCV titrations by more conventional and 
also more accurate means, a working limit was placed on this category. 
The virus titer of tissues from HC affected swine usually does not exceed 
6 6 10 • Therefore, the upper limit was set at 10 and the average titer 
assigned to samples within this category was 105• 
All titrations were made at the 16-24 hr examination of cell cultures 
except in the few instances when samples were found positive only at t he 
40-48 hr examination. These samples were placed in category 1. 
Titers are expressed for the 2 ml of sample inoculum used to infect 
cell cultures. Even though spleen t i ssue was diluted approximately 1: 4 
in the preparation of cell cul t ure inoculum, no adjustment was made f or 
this dilution, i.e., the observed titer was not multiplied by 4. 
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RESULTS 
From May 31, 1963 to June 2, 1964, samples were received from 338 
suspected cases of HC occurring in 22 states (Table 1). A diagnosis of 
HC was confinned by the FATCT on 225 (67%) of the suspected cases. Two 
-.;_ 
Table 1. State of origin of 338 suspected cases of HC from which 
samples were received 
State of origin Number of cases a State of origin Number of cases 
Iowa 197 Florida 2 
Missouri 80 Massachusetts 2 
Indiana 23 California 2 
Tennessee 5 North Dakota 1 
South Dakota 3 Washington 1 
Illinois 3 Minnesota 1 
Arizona 3 New Jersey 1 
Alabama 3 Virginia 1 
Ohio 3 Colorado 1 
Wisconsin 2 Georgia 1 
Kansas 2 Rhode Island 1 
Total 338 
a 
Samples from most of the cases occurring in Iowa were submitted 
by Iowa veterinary practitioners and personnel of the Iowa State 
University Veterinary Diagnostic Laboratory; most of those from other 
states were submitted by personnel of the Animal Health Division, 
Agricultural Research Service, U. s. Department of Agriculture. 
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hundred and twenty (98%) confinnations were made at the first, i.e. 16-24 
hr, examination of infected coverslip cultures, whereas 5 (3i.) confir-
mations required the examination of infected cell cultures that had been 
incubated 40-48 hrs. 
From the 338 cases, a total of 918 samples were received, of which 
490 were spleen and 428 were blood. The FATCT was performed with only 
850 of the samples since 68 (7%) were either markedly decomposed or 
adulterated. Hog cholera virus was isolated and identified by the FATCT 
from 502 (59%) of the 850 samples examined (Table 2). 
Table 2. Results of FATCT with samples from suspected field ~ases of HC 
FATCT results with individual 
Diagnosis of % field samples 
HC based Number of total Spleen Blood 
on FATCT of cases cases Number % Eositive Number % Eositive 
Positive 225 66.6 324a/348 93.1 178/286 62.2 
Negative 97 28.7 0/123 • • • • 0/93 •••• 
None 
b 
16 4.7 • • • • • ••• • • • • •••• 
Total 338 100 
~umerator s number FATCT positive; denominator • number examined 
by FATCT. 
bAll the samples from 16 suspected cases of HC were too decomposed 
or adulterated to examine by FATCT. 
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All 3 anti-HC sera used to prepare fluorescent antibody were found 
satisfactory. No significant difference was observed between any of these 
sera. 
No particular difficulties were encountered in conducting the FATCT 
except those directly related to the condition of samples. These 
difficulties, however, caused an alteration in the method of performing 
the test. A preliminary study (49), indicated that a satisfactory method 
of testing samples was to inoculate 0.2 ml of a tissue suspension, plasma 
or serum directly into the nutrient medium of a cell culture. The 
inoculum was allowed to remain in the medium during the subsequent 
incubation of the culture. For 2 reasons, this technique did not suffice 
-
for the testing of field samples. Field samples were often heavily 
contaminated with bacteria; therefore, vast numbers of these bacteria 
were introduced into the cell culture medium with the tissue inoculum. 
In spite of the antibiotics in the medium, the bacteria occasionally 
multiplied to sufficient numbers to destroy the culture. Secondly, some 
of the decomposed samples were "borderline" toxic. Cell cultures could 
withstand the toxic effect of these samples only if the exposure to them 
was for a relatively short time. For the above reasons, an alternate 
method of testing was followed. This procedure is described in detail 
in MATERIALS AND METHODS. Briefly, it involved the inoculation of the 
test material directly onto the cell culture. After exposing the cells 
to the inoculum for l hr, the cultures were carefully washed. Fresh 
medium was then added. In this manner most of the bacteria and toxic 
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materials were removed from the culture. One added advantage of the 
latter method was that most of the cell debris, present in tissue 
suspensions, was also removed from the culture. Without washing• some 
of the debris remained affixed to the cell monolayer throughout subsequent 
processing for FATCT examination. Although the autofluorescence of these 
tissue fragments did not resemble specific fluorescence of infected cells. 
it nevertheless was undesirable. 
Comparison of Spleen and Blood Samples 
As a diagnostic sample. spleen was superior to blood in 2 ways. 
The most important was that spleen samples from swine herds• wherein a 
FATCT diagnosis of RC was made• were more frequently positive than were 
blood samples from these same herds (Table 2). Of less importance, but 
yet interesting. is the fact that generally more infective HCV was 
isolated from spleen than blood (Tables, 3. 4, s. 6. and 7). It will be 
noted that all FATCT-positive spleen and blood samples represented in 
Table 2 are not found in Tables 3. 4, s. 6 and 7 since the estimate of 
the HCV content of samples was not initiated until sometime after this 
evaluation study had been started. It is obvious from the examination 
of Table 3, that spleens generally contained more infective HCV than did 
blood samples. However, to more adequately compare these samples , the 
average virus titer of all spleen samples (Table 4) was compared to that 
of blood samples (Table 5). The comparison was made by dividing the 
average HCV titer of spleen samples, 31,306, by the average HCV titer of 
31 
Table 3. Estimated HCV content of field samples 
a 
Type of Infective units of HCV/2 ml of sample 
sample 1-10 11-100 101-1000 1001-10,000>10,000 Total 
Number 25 18 49 103 81 276 
Spleen 
%b 9.1 6.5 17.8 37.3 29.3 
Number 38 30 20 25 33 146 -Blood 
i. 26.0 20.6 13.7 17.1 22.6 
Number 63 48 69 128 114 422 
Total 
%c 14.9 11.4 16.4 30.3 27.0 100 
~he method of estimation is described in MATERIALS AND METHODS. 
b% of total spleen samples represented in the table. 
c% of all samples represented in the table. 
blood samples. 23 1 539. The ratio thus obtained was 1,33 1 demonstrating 
that approximately_ 33% more HCV was identified from spleen than from blood. 
This type of comparison could be misleading. For example. if 50 
spleens (each of 49 containing 1 infective unit and 1 containing 100,000 
infective units) were compared with 50 blood samples (each containing 1,000 
infective units) the following results would be obtained: average HCV 
titer spleen a 2001, average HCV titer blood a 1000, ratio spleen: blood • 
2. Although mathematically correct, the single spleen sample containing 
100,000 infective units biased the results; therefore, another method was 
also used for comparison. Samples, spleen or blood, were placed into 1 of 
Table 4. 
Category 
number 
1 
2 
3 
4 
5 
32 
a Average HCV titer of spleen samples 
Infective units 
of HCV/2 ml of 
sample 
1-10 
11-100 
101-1000 
1,001-10,000 
>10,000 
Average number 
of infective 
units/2 ml 
of sample 
5 
50 
500 
5,000 
100,000b 
Total 
Number of 
samples/ 
category 
25 
18 
49 
103 
81 
276 
Total infective 
units of HCV/ 
category 
(samples x 
average titer) 
125 
900 
24,500 
515,000 
8,100,000 
8,640,525 
Average HCV titer of spleen samples ~ 8,640,525 t 276 .. 31,306 
8Based on data presented in Table 3. 
bThe method by which this average titer was determined is 
described in MATERIALS AND METHODS. 
5 categories depending on the number of infective units of HCV in a 2 
ml portion of the sample. A sample was assigned a value corresponding 
to the number of the category in which it was placed. Samples with the 
least amount of virus were placed in category 1 and each was assigned a 
value of 1. Samples with the most virus were placed in category 5 and 
each was assigned a value of 5. Samples containing virus concentrations 
between these 2 extremes were appropriately placed in either categories 
2, 3 or 4 and were assigned the corresponding values (Tables 6 and 7). 
Table 5. 
Category 
number 
1 
2 
3 
4 
5 
33 
a Average HCV titer of blood samples 
Infective units 
of HCV/2 ml of 
sample 
1-10 
11-100 
101-1000 
1,001-10,000 
>10,000 
Average number 
of infective 
units/2 ml 
of sample 
5 
50 
500 
s,ooo 
100,000b 
Total 
Number of 
samples/ 
category 
38 
30 
20 
25 
33 
146 
Average HCV titer of blood samples :: 3,436,690 f 146 -
~ased on data presented in Table 3. 
Total infective 
units of HCV/ 
categor y 
(samples x 
average titer) 
190 
1,500 
10,000 
125,000 
3,300,000 
3,436, 690 
23,539 
b 
The method by which this average titer was determined is 
described in MATERIALS AND METHODS . 
This method, which will be referred to as the assigned value method, 
prevented bias by a few samples containing a large number of infective 
units of HCV. The average assigned value of spleen is 3.7 (Table 6) 
and the average assigned value of blood is 2.9 (Table 7). The 
comparative ratio (3.7 : 2.9) is 1.28. In this case, because of the 
distribution of samples , the ratio of the 2 types of samples is similar 
by either method of comparison. 
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Table 6. Average numerical value of spleen samples based on their 
relative HCV contenta (assigned value method) 
Numerical value Total numerical 
assigned to each value/category 
Category Number of sample of a (samples x numerical 
number samples/category category value/sample) 
1 25 1 25 
2 18 2 36 
3 49 3 147 
4 103 4 412 
5 81 5 405 
Total 276 1.025 
Average numerical value of spleen samples= 1025 t 276 • 3.7 
'13ased on data presented in Table 3. 
Laboratory Samples 
Two hundred and ninety-five blood samples and 4 spleen samples were 
obtained from pigs either injected with field specimens or injected with 
blood obtained from pigs injected with field specimens or from pigs 
exposed by contact to the pigs mentioned above. All except 1 of these 
samples. which will be referred to hereafter as laboratory samples. were 
examined by the FATCT. The results of these tests are more meaningfully 
presented in relation to the reaction of the pigs from which the samples 
were obtained. Consequently they are presented in detail in the following 
sections on the SWINE INOCULATION TEST (SIT) results and on the correlation 
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Table 7. Average numerical value of blood samples based on their 
relative HCV contenta (assigned value method) 
Numerical value Total numerical 
assigned to each value/category 
Category Ntmlber of sample of a (samples x numerical 
number samples/category category value/sample) 
1 38 1 38 
2 30 2 60 ·~ 
3 20 3 60 
4 25 4 100 
5 33 5 165 
Total 146 423 
Average numerical value of blood samples • 423 f 146 • 2.9 
8Based on data presented in Table 3. 
of FATCT and SIT results. It suffices to state here that of the 294 
blood samples examined by the FATCT, 238 were positive and of the 4 
spleens examined, 2 were positive. 
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PART II. SWINE INOCULATION TEST 
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MATERIALS AND METHODS 
Hog Cholera Susceptible Swine 
Thirty to 60 lb SPF-1 and SPF-2 swine of various breeds and Yorkshire 
(York) swine from the NADL purebred, inbred herd were used for the majority 
of the SIT's. These types of swine were selected because it was be! ieved 
that their susceptibility to HCV was more unifonn than that of average 
farm-raised swine. 
Inoculation, Bleeding and Subsequent Challenge of Swine 
A composite or pool of inoculae prepared from the individual samples 
of a specimen was used for swine inoculation. Routinely , 4 ml of the pool 
was injected subcutaneously; however, in some instances the inoculum that 
a pig received was either more or less than the 4 ml amount. Occasionally, 
there was an insufficient amount of the field sample(s) to provide the 4 
ml volwne. After injection, the pig was placed in an isolation cage. 
Controlled experiments had been conducted to demonstrate that these 
isolation facilities were reliable.* 
At least one, 100 ml blood sample was subsequently obtained from most 
of the pigs which received FATCT-positive specimens. Blood samples were 
also taken from pigs which had an obvious clinica l reaction after receiving 
FATCT-negative specimens or s pecimens not examined by the FATCT. Occasion-
ally blood samples were taken from pigs which received FATCT-negative 
*Conducted by J. P. Torrey , NADL, Ames, Iowa. 
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specimens and which did not have a clinical reaction. In addition, 4 
spleen samples were taken at autopsy. These laboratory samples were 
processed and examined by the FATCT in a manner identical to that employed 
for those from the field except that only 1 coverslip cell culture was 
inoculated with each sample. The cultures were examined 16-24 hrs later. 
The portion of each laboratory sample which was not used for the FATCT was 
stored at -60 C for future reference. 
The majority of the blood samples were obtained 6-8 days after the 
pigs were injected with field specimens, but the time of bleeding depended 
primarily on the reaction of the pig. Pigs were usually bled during a 
period of marked clinical illness and consequently , during a period when 
a viremia was most likely to occur. Obviously, the time of bleeding could 
not be so advantageously selected when pigs received field isolates of HCV 
which were of low virulence. 
Pigs which did not die or were not killed in a moribund condition 
after receiving a field specimen were subsequently moved to an isolation 
room and challenged with 2 ml of swine blood containing Ames HCV. If a 
pig had had no clinical reaction, it was challenged approximately 2 weeks 
after receiving the field specimen. If a pig had a reaction but recovered, 
it was challenged after it had been clinically normal for approximately l 
week, providing the date of challenge was approximately 2 weeks or more 
after the pig had been injected with the field specimen. The above inter-
vals of time were increased in some instances when SIT's were repeated 
with several of the field specimens. 
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Usually a pig was removed from its i solation cage only for bleeding 
and/or challenge. Exceptions were made when it was desirable to study 
the reactions of pigs in greater detail. For this purpose, pigs were 
placed in isolation rooms. 
Interpretation of Swine Inoculation Tests 
A SIT was recorded as positive if after injection with a specimen, 
the pig either died or was killed in a moribund condition and had lesions 
suggestive of HC. A SIT was also recorded as positive if a pig survived 
after injection with a specimen and was found immune when subsequently 
challenged with Ames HCV. 
A SIT was recorded as negative if the pig survived after injection 
with a field specimen but died or was killed in a moribund condition after 
challenge with Ames HCV. 
The f ew exceptions to the above general s tatements will be pointed 
out in RESULTS. 
Quantitation of the Reaction of Pigs Confined to Isolation Cages 
The severity of the illness of pigs confined to isolation cages was 
evaluated on the basis of a daily point system. One point was recorded 
for a pig which was slightly anorectic and had slight or no definite de-
pression. A pig having moderate anorexia and depression was given 2 points 
and a pig having complete anorexia and severe depression was given 3 points. 
If the daily point accumulation was 11 or less, the overall reaction was 
defined as slight. If t he daily point accumul at i on was more than 11, the 
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overall reaction was defined as moderate to severe. The general con-
.finement of pigs to isolation cages precluded more definitive measures 
of their reactions. 
Classification of Hog Cholera Viruses 
Each field isolate of HCV was classified as either lethal or 
inmunizing depending on the reaction of the pig infected with the 
respective isolate. To more adequately indicate their relative 
virulence, lethal viruses were subclassified according to the duration 
of illness of the infected pig prior to death. This excluded the 
incubation period and any temporary recovery periods. Immunizing 
viruses were subclassified according to the severity of the pig's 
reaction prior to recovery and subsequent challenge. The classifi-
cation scheme is outlined below. 
I. Lethal Viruses (L) 
1 less days of illness preceding death. L -----10 or 
2 L -----11 to 21 days of illness preceding death. 
3 L ----21 to 31 days of illness preceding death. 
4 L -----31 or more days of illness preceding death. 
II. Immunizing Viruses (I) 
1 I -----causing a moderate to severe reaction prior to recovery. 
2 I -----causing no r eaction or a slight reaction prior to 
recovery. 
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Repeated Swine Inoculation Tests 
Routinely, each field specimen was injected into 1 pig. However, 
for several reasons additional SIT's were conducted. If a pig which had 
been injected with a field specimen died within 24 hrs after a blood 
sample had been taken from the anterior vena cava, usually another pig 
was injected with the same specimen. The possibility existed that -the~ 
cause of death was mechanical injury due to bleeding. In most _instances 
when the results of the FATCT and the SIT did not agree, the SIT was 
repeated. Occasionally, 2 or more pigs were injected with the same 
specimen to compare the reactions of these pigs to the same field isolate 
of HCV. 
Definition of Tenns 
Several terms will be used repeatedly in the following text and 
tables. - Their meanings may be obvious but to avoid possible confusion 
they are defined here. 
Incubation period -- The number of days from injection or other 
means of exposure of a pig to HCV to the first clinical signs of illness. 
Temporary recovery period -- A period, following a clinical reaction, 
during which a pig had a normal appetite and was alert, irrespective of 
its temperature. However, usually the temperature corresponded to the 
degree of clinical illness that was observed. 
Duration (or days) of illness preceding death The number of days 
of observed clinical illness of a pig . This excludes the incubation 
period and any temporary recovery periods. 
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Total days, exposure to death -- The number of days from injection 
· or other means of exposure of a pig to HCV to the death of that pig . In 
some instances this interval cannot be obtained by simply adding the 
incubation period to the days of illness preceding death since l or more 
temporary recovery periods occurred, e.g., see Table 17. 
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RESULTS 
Two hundred and thirty-eight (70%) of 338 suspected cases of HC were 
confirmed by SIT's. Six cases were recorded as questionable based on the 
contradictory results of several SIT's done with the corresponding 
specimens. Eighty-six cases were SIT negative. Specimens from the 
remaining 8 cases were excessively decomposed and were not injected into 
pigs (Table 8). 
Table 8. Results of SIT's with specimens from suspected field cases of 
HC 
Diagnosis of HC 
based on SIT's 
Positive 
Negative 
Questionable 
a 
None 
Total 
Number 
of cases 
238 
86 
6 
8 
338 
% of 
total cases 
70.4 
25.4 
l. 8 
2.4 
100 
a All the samples from these 8 cases were severely decomposed and 
were not injected into pigs. 
Classification of Hog Cholera Viruses 
It was possible to determine the relative virulence of 222 field 
isolates of HCV (Table 9). Although a diagnosis of HC was confirmed on 
238 cases, pigs injected with 16 of the field isolates (specimens 
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Table 9. Classification of virulence of 222 field isolates of HCV 
Classification of virulence a 
Lethal (L) Immunizing (I) 
Number of isolates 
% of total isolates 
classified 
Number of isolates 
% of total isolates 
classified 
11 
72 
32.4 
12 13 
86 11 
38.7 5.0 
177 
79.7 
14 Il 12 
8 16 29 
3.6 7.2 13.1 
45 
20.3 
a Classification scheme repeated in part from MATERIALS AND METHODS 
for convenience of reference: 
Lethal (L) -- Killed' the experimentally infected pig, sub-
classified on the basis of the duration of illness of the 
pig preceding death. 
L1 10 or less days of illness preceding death. 
12 10 - 21 days of illness preceding death. 
1 3 21 - 31 days of illness preceding death. 
14 31 or more days of illness preceding death. 
Immunizing (I) -- Immunized experimentally infected pig against 
subsequent challenge with Ames HCV, subclassified on the basis 
of the severity of reaction prior to recovery and subsequent 
challenge. 
r 1 -- moderate to severe reaction prior to recovery. 
12 -- no reaction or slight reaction prior to recovery. 
containing HCV) were killed in a moribund condition. These 16 isolates, 
therefore, could not be accurately subclassified, but there is little 
doubt that t hey may be considered as lethal viruses. Virus classification 
was based on the first positive SIT conducted with the respective isolate. 
'..i.. 
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It will be noted from Table 9 that 177 field isolates of HCV were 
classified as lethal. If the 16 isolates mentioned above are added to the 
177 from Table 9, it is found that only 81% of the HCV's from naturally 
occurring cases of HC killed experimentally infected pigs. 
The relative virulence of Ames HCV was also determined. Since many 
pigs were injected with field specimens which apparently did not contain 
HCV, the virus classification scheme was applied to the reactions of these 
pigs after challenge with Ames HCV. Pigs which died following challenge 
but which previously had any reaction after injection with the field 
specimen were excluded from consideration. Although these pigs were 
clinically normal at the time of challenge, it was possible that they 
still harbored a pathogenic agent other than HCV which would contribute 
to their death following challenge. In addition, many of the challenged 
pigs were killed in a moribund condition to provide space for other SIT's. 
The reactions of 37 pigs remained for consideration after exclusion of 
many SIT's for various reasons, primarily those mentioned above. Ames 
HCV was classified as L1 in 33 instances and L2 in 4 instances. 
Swine Inoculation Tests with Specimens 
Obtained from Various Sources 
The percentage of SIT confirmed cases of HC was greatest for those 
cases investigated by personnel of the Animal Health Division (Table 10). 
Furthermore, generally more virulent HCV's were present in specimens 
submitted by this source (Table 11). 
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Table 10. Results of SIT's with specimens obtained from various sources 
Source of specimens 
Iowa State 
University 
Diagnosis of Veterinary Animal 
HC based on Veterinary Diagnostic Health 
SIT's practitioner Laboratory Division 
Number a i.b Number i. Number % 
Positive 76 63.9 35 54.7 127 90.l 
Negative 43 36.1 29 45.3 14 9.9 
Questionable 4 •••• • ••• • ••• 2 • ••• 
None c 6 2 • • • • • ••• •••• I I I I 
Subtotal 129 64 145 
Total 338 
~umber of cases. 
b % of total cases from respective source, excluding the questionable 
cases and those for which specimens were not injected into pigs. 
cAll samples from these cases were excessively decomposed and were 
not injected into pigs. 
Repeated Swine Inoculation Tests 
Several specimens containing HCV were injected into 2 or more pigs 
to determine if a particular isolate would cause a similar reaction in 
different pigs; thus, in effect, ascertaining the reliability of the 
virus classification data. The first test conducted with each isolate 
was used for its virulence classification. It was necessary to 
•.i.. 
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Table 11. Relative virulence of 222 field isolates of HCV from various 
sources a 
Source of field isolates 
Iowa State 
University 
Veterinary Animal 
Diagnostic Health 
Virulence 
classification of 
field isolates 
Veterinary 
practitioner Laboratory Division 
Highly virulent 
(L 1 and L 2) 
Moderately 
virulent 
Immunizing 
(I l and I 2) 
Ntunber 44 
61.1 
Number 7 
% 9.7 
Number 21 
29 .2 
--17 97 · 
53.1 82.2 
3 9 
9.4 7.6 
12 12 
37.5 10.2 
~he source of the additional 16 lethal field isolates that were 
not subclassified is as follows. Veterinary practitioner 4, Iowa 
State University Diagnostic Laboratory 3, and Animal Health Division 9 . 
b -
% of total isolates from respective source. 
arbitrarily select SIT 8472 to classify field isolate 346 since both 
SIT 's were conducted on the same day (Table 12). With the exception of 
4 viruses classified as L , multiple t ests with field isolates classified 
as lethal are presented in Table 12. Multiple tests with field isolates 
classified as immunizing are presented in Table 13. Some of the tests 
were repeated for purposes other than to compare the reactions of several 
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Table 12. Multiple SIT's with field isolates of HCV which were classified 
as lethal 
Duration 
of illness 
Test pig preceding Virus 
HCV description death of classification 
isolate SIT (pig) Weight Date SIT infected based on the 
number number T;:tEe ~lbs2 conducted PiS ~dais~ res:eective SIT 
21 7411 40 L3 SPF-1 7-31-63 23 
7461 SPF-1 50 8-9-63 a Il •••• 
85 7550 SPF-1 40 11-18-63 3 Ll 
7769b SPF-1 55 12-2-63 6 Ll 
208 7960 SPF-2 35 3-17-64 5 Ll 
8478 SPF-1 45 11-13-64 8 Ll 
8479 SPF-1 45 11-13-64 10 Ll 
213 7956 SPF-2 50 3-17-64 5 Ll 
8324 SPF-2 39 8-26-64 18 L2 
233 •••• SPF-2 90 3-27-64 13 L2 
8375 SPF-2 47 9-21-64 16 L2 
237 7906 SPF-2 90 3-27-64 10 Ll 
8466 SPF-1 37 11-13-64 11 L2 
8470 SPF-1 37 11-13-64 9 Ll 
243 8009 SPF-2 50 4-2-64 7 Ll 
8463 SPF-1 46 11-13-64 4 Ll 
8468 SPF-1 36 11-13-64 10 Ll 
282 8081 SPF-2 25 4-20-64 10 Ll 
8465 SPF-1 42 11-13-64 17 L2 
8476 SPF-1 43 11-13-64 7 Ll 
8Recovered after 16 days of illness and was found immune when 
subsequently challenged. 
binjected with a blood sample from pig 7550. 
.... 
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Table 12 (Continued) 
Duration 
of illness 
Test pig preceding Virus 
HCV description death of classification 
isolate SIT (pig) Weight Date SIT infected based on the 
number number Type (lbs) conducted pig (days) resnective SIT 
292 8099 SPF-1 50 4-29-64 15 L2 
8387 SPF-2 32 9-21-64 13 L2 
•.i.. 
336 8166 SPF-2 50 5-30-64 25 L3 
8475 SPF-1 47 11-13-64 19 L2 
8477 SPF-1 46 11-13-64 6 Ll 
345 8168 SPF-2 47 5-30-64 28 L3 
8391 SPF-2 26 9-21-64 16 L2 
346 8472 SPF-1 36 11-13-64 10 Ll 
8473 SPF-1 30 11-13-64 11 L2 
pigs, nevertheless, they are appropriately included here. Apparently there 
was no general tendency for isolates to lose v irulence during storage nor 
to cause a more or less severe reaction in SPF-1 than in SPF-2 pigs . 
Except for lethal viruses 21 and 336, the pig reactions were fairly 
constant to a particular isolate. 
Swine inoculation tests were repeated with specimens from 11 suspected 
cases of HC because the FATCT's had been negative whereas the corresponding 
SIT's had been positive. Five of the repeated tests were positive and 6 
were negative. The latter 6 cases comprise the previously mentioned 
questionable group of SIT results (Table 14). Specimens from 3 other cases 
were FATCT negative and SIT positive but were not injected into additional 
pigs. 
Table 13. Multiple SIT's with field isolates of HCV which were classified as immunizing 
HCV 
isolate 
number 
18-19-20 
22-44 
158 
SIT (pig) 
number 
7407 
7526 
8474a 
7462 
7548 
8460 
9431b 
8327b 
Test pig 
description 
Weight 
Type (lbs) 
SPF-1 60 
York 42 
SPF-1 36 
SPF-1 55 
SPF-1 45 
SPF-1 33 
SPF-1 50 
SPF-2 38 
a Injected with blood from pig 7526. 
Severity 
of illness 
prior to Virus 
recovery and classification 
Date SIT subsequent based on the 
conducted challenge respective SIT 
7-30-63 No reaction 12 
8-21-63 Slight 12 
11-13-64 Slight 12 
8-2-63 Slight 12 
9-13-63 Slight 12 
11-13-64 Slight 12 
2-26-64 Slight 12 
8-26-64 Slight 12 
b Injected with a FATCT positive blood sample from pig 7882 (not represented in the table) 
which, in turn, had been injected with FATCT positive field specimen 158. Pig 7882 had no 
reaction after receiving the field specimen but died following challenge with Ames HCV. 
~ 
'° 
Table 14. SIT results with specimens from 6 suspected cases of HC on which a SIT diagnosis of 
HC was questionable 
Case SIT (pig) Date SIT SIT FATCT 
nwnber number conducted results a resultsb Remarks 
47 7552 9-20-63 + -. + The pig had no definite reaction until 10 
days post field specimen inoculation 
(PFSI). Blood samples were taken on the 
7th and 15th day PFSI. The 7th day blood 
sample was FATCT negative. The 15th day 
blood sample was positive. 
8332 8-26-64 • • • • •••• 
53 9612 9-25-63 •••• • ••• The pig died 4 days PFSI. Er;i::si:eelothrix 
insidiosa was -isolated from its visceral 
organs. No samples were obtained for 
FATCT examination. 
9616 10-2-63 + + Inoculum filtered before injection. 
8382 9-21-64 •••• Inoculum not filtered. 
55 7600 9-27-63 + + •••• 
8462 11-13-64 • • • • •••• 
167 7887 2-10-64 + • • • • •••• 
8461 11-13-64 • • • • •••• 
8467 11-13-64 •••• The pig was killed 6 days PFSI. Spleen 
and blood were examined by FATCT. Both 
were negative. 
a+ • positive; - • negative. Also applies to FATCT results. 
b from test pig. Blood sample ~· 
Vt 
0 
Table 14 (Continued) 
Case SIT (pig) Date SIT 
number number conducted 
279 7915 4-17-64 
8100 4-29-64 .. 
8386 9-21-64 
296 8098 4-29-64 
8374 9-21-64 
SIT FATCT 
resultsa resultsb 
+ + 
•••• 
• • • • 
+ + 
. . . . 
Remarks 
No microscopic lesions of RC were observed 
in a brain submitted from this herd.c 
The pig died shortly after a blood sample 
was taken on the day the pig was to be 
challenged. Neither HCV nor homologous 
antibody was detected in the sample. 
•••• 
No microscopic lesions of RC were observed 
in a brain submitted from the herd. 
Leukocyte counts were elevated. 
•••• 
c Brain examinations done by R. A. McDaniel , NADL, Ames, Iowa. 
,:. 
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Swine inoculation tests were repeated with specimens from 6 field 
cases because the FATCT's had been positive whereas the corresponding 
SIT's had been negative. Repeated tests were all positive (Table 15). 
Table 15. Repeated SIT's with specimens from 6 suspected cases of HC. 
The first SIT was negative, whereas the corresponding FATCT 
was positive :i.. 
Approximate 
Case SIT (pig) Date SIT HCV titer SIT FATCT 
mn:nber number conducted of inoculum resultsa resultsb 
109 7776 12-17-63 103 + 
8331 8-26-64 103 + •••• 
158 7882 2-4-64 >104 + 
943lc 2-26-64 103 + 
8327c 8-26-64 103 + •••• -
219 7964 3-21-64 104 + 
8326 8-26-64 104 + •••• 
300 8105 4-29-64 <101 + 
8376 9-21-64 <101 + + 
331 8148 5-21-64 103 + 
8385 9-21-64 103 + + 
342 8163 5-30-64 103 
8379 9-21-64 103 + •••• 
a + = positive; - • negative. Also applies to FATCT results. 
b 
Blood sample from test pig. 
c Injected with blood from pig 7882. 
53 
The negative results of the first SIT's were based on the failure of the 
test pig to survive subsequent challenge with Ames HCV. However, it is 
apparent that the first pigs injected with isolates 109, 158, 219, 300, 
and 331 had been infected with HCV prior to challenge since blood samples 
taken from them were FATCT positive. Although the blood sample obtained 
from the pig injected with isolate 342 was negative, it is probable that 
this pig was also infected prior to challenge. Therefore, the negative 
results were apparently not caused by the failure of the pigs to become 
actively infected following injection of the field specimen. The HCV 
titer of the total inoculum each pig received was approximated by averaging 
the titers of the respective samples from which the inoculum was prepared. 
It was necessary to classify these isolates by the results of the second 
SIT since the first test had been negative. Isolates 109 and 158 were 
classified as I
2
; isolate 342 as I
1
; isolates 300 and 331 as L
4
; and 
isolate 219 as L
2
• 
Investigations with Field Isolates of Hog Cholera Virus 
Which Caused Prolonged Reactions in Experimentally Infected Pigs 
Field isolates 7, 12, 92, 138 , 300, 310, 331 and 348 were classified 
as L4• By definition of L4 , the infected pigs were ill for a minimum of 
30 days preceding death (Table 16). The SIT's which are found in the 
table for isolates 300 and 331 are the second tests conducted with them. 
As previously pointed out in the text and in Table 15, the first test 
with each of these isolates was negative. 
Table 16. 
Isolate 
number 
7 
12 
92 
138 
300 
310 
331 
348 
4 Swine inoculation test results with field isolates of HCV classified as L 
SIT (pig) 
munber 
7361 
7366 
7765 
7816 
8376 
8124 
8385 
8161 
Test pig 
description 
Weight 
Type (lbs) 
SPF-2 40 
SPF-2 30 
SPF-1 50 
York 130 
SPF-2 44 
SPF-2 60 
SPF-2 33 
SPF-2 53 
Days of 
illness 
preced-
ing 
death 
54 
46 
36 
42 
91 
36 
46 
34 
Clinical reactions of infected pigs 
Duration 
Nt.mlber 
of 
temporary 
recovery 
periods 
1 
1 
2 
1 
3 
1 
7 
None 
of 
longest 
recovery 
period 
(days) 
4 
6 
5 
5 
9 
2 
34 
•••• 
Average 
points 
per day 
of 
illness8 
1.61 
1.76 
1.97 
2.67 
1.13 
2.11 
1.26 
2.76 
Total 
days 
exposure 
to death 
60 
54 
50 
51 
104 
42 
100 
35 
FATCT 
resultsb 
1+, 44+, so+ 
6+, 43+ 
14+, 48+ 
6+, so+ 
73+, 85+ 
7-
73+, 85+ 
7+ 
a 
Accumulated daily points f days of illness preceding death. The point system is 
described in MATERIALS AND METHODS. 
b 
Blood samples from experimentally infected pigs. Number indicates on which day after 
injection of the field isolate that the blood sample was taken, + • positive; - a negative. 
~·. 
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With 1 exception, all pigs had temporary recovery periods lasting 
from 1-34 days. Even though several pigs were moved to isolation rooms 
during their illness, the criteria used to determine if they were 
clinically normal was the same as had been used during isolation cage 
confinement. That is, if a pig had a normal appetite and was alert, it 
was recorded as clinically normal. This was done to interpret clinical 
reactions on a uniform basis. However, other criteria made it obvious 
that the recovery periods were only apparent. The most definitive was 
that the pigs eventually relapsed and died as a consequence of HCV 
infection. In some instances temperatures were elevated on days when a 
pig appeared normal. For example, the temperatures of pig 8385, infected 
with isolate 331, ranged from 102.8 - 104.8 F during its 34 day temporary 
recovery period. Moreover , the FATCT results indicated a persistent 
viremia. 
The overall severity of a pig's reaction was quantitated by the 
daily point system defined in MATERIALS AND METHODS. Although all these 
4 isolates were classified as L , some caused a generally severe reaction 
and some a rather mild reaction. 
The long period of time which elapsed between exposure and death of 
pigs 8376 and 8385 stimulated considerable interest in them. Pig 8376 
survived for 104 days following infection but during this time became 
extremely emaciated (Fig . 5). Pig 8385 gained weight during the 100-day 
interval prior to death (Fig . 6). There was also a significant difference 
in the gross lesions observed at autopsy. Lesions of pig 8376 were 
Fig. 5. Pig 8376, 80 days after injection with field isolate 300 
Fig. 6, Pig 8385, 80 days after injection with field isolate 331 
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. .._ 
primarily associated with the intestinal tract (Figs. 7, 9 and 11), 
whereas those of pig 8385 were primarily pneumonic (Figs. 8, 10 and 12). 
Several experiments were conducted by exposing HC susceptible pigs 
to pigs infected with isolates 7, 300 and 331 (Table 17). Exposure was 
accomplished by placing the susceptible contact in an isolation room 
with the infected pig. They were separated by a partition which allowed 
only minimal physical contact . An exception was made in 1 instance when 
2 pigs were allowed direct contact for a few hrs (pigs 7361 and 7527). 
A marked difference existed between the results obtained with each 
of these isolates. In a single passage, isolate 7 appeared to increase 
in virulence and cause an acute reaction in the contact pig. Isolate 300 
irranunized the first contact and apparently did not spread to the second 
contact. Isolate 331 spread to all 3 contacts and in the process of serial 
passage increased somewhat in virulence. Nevertheles·s, it continued to 
cause a relatively long and low grade reaction. 
The reason for the lack of spread of isolate 300 from pig 8499 to pig 
8538 may be explained by correlating information in Table 17 with that in 
Table 18. On the first day of contact between these pigs, pig 8499 no 
longer had a viremia as evidenced -by the FATCT. It seems likely that pig 
8499 had recovered from its initial infection with HCV and was no longer 
disseminating virus. 
It is evident from Table 18 that in the later stages of illness prior 
to death, leukocyte counts were not always a good indication of HCV 
infection. It is also evident that with these particular viruses a pig's 
Fig. 7. Stomach and intestines from pig 8376 
Fig. 8. Stomach and intestines from pig 8385 
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, 
Fig. 9. Lung from pig 8376 
Fig. 10. Lung from pig 8385 
62 
Fig. 11. Kidney , adrenal and spleen from pig 8376 
Fig. 12. Kidney , adrenal and spleen from pig 8385 
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Table 17. Contact experiments with 3 field isolates of HCV classified as L 
4 
Clinical reaction of 
infected pigs 
Test pig Inc uh a- Days of Total 
description ti on illness days 
Isolate SIT (pig) Weight time preced- (exposure 
number number Type (lbs) Method of infection (days) ing death to death) 
7 7361 SPF-2 40 Injection of specimen 7 2 54 60 
7527 York 40 Exposure to pig 7361 (51 days 2 10 12 
after 7361 had been injected 
with specimen 7) 
300 8376 SPF-2 44 Injection of specimen 300 1 91 104 
8499 SPF-1 45 Exposure to pig 8376 (99 days No clinical reaction except 
after 8376 had been injected 2 days of slightly elevated 
with specimen 300) temperature (104 and 
104.2 F)a 
b °' 8538 SPF-1 48 Exposure to pig 8499 (20 days No clinical reaction \JI 
after 8499 had been exposed 
to pig 8376) 
aChallenged 41 days after exposure. Inrnune. 
b Challenged 21 days after exposure. Died following challenge. 
Table 17 (Continued) 
Clinical reaction of 
infected pigs 
Test pig Incuba- Days of Total 
description ti on illness days 
Isolate SIT (pig) Weight time preced- (exposure) 
number number Type (lbs) Method of infection (days) ing death to death) 
331 8385 SPF-2 33 Injection of specimen 331 1 46 100 
8498 SPF-1 40 Exposure to pig 8385 (99 days 8 36 44 
after 8385 had been injected 
with specimen 331) 
8537 SPF-1 49 Exposure to pig 8498 (20 days 3 24 27 
after 8498 had been exposed 
to pig 8385) 
8547 SPF-1 so Exposure to pig 8537 (21 days 6 24 30 °' °' after 8537 had been exposed 
to pig 8498) 
f. 
Table 18. Laboratory tests with samples obtained from pigs infected with field isolates of HCV 
300 and 331 
Day 
Isolate SIT (pig) Source of samples Clinical Tempera- Leukocyte EAT CT resultsc 
number number infection obtaineda reactionb tu re count Blood Feces Saliva 
300 8376 Specimen 300 73 Slight 103.8 • • • • + •••• • ••• 
85 Slight 102.6 124,800 + + 
8499 Exposure to 9 None 102.8 14,000 + •••• • ••• 
pig 8376 20 None 102.6 21,500 •••• • ••• 
30 None 102.4 21 , 650 •••• • ••• 
41 None •••• 18,600 • ••• • ••• 
8538d Exposure to 10 None 102.2 25,800 • • • • •••• 
pig 8499 21 None •••• 18,400 • • • • • ••• 
~he number of days after injection of a specimen or exposure to an infected pig. 
b On the particular day samples were obtained. 
c + • positive; - • negative. 
d Apparently not infected. Died following subsequent challenge with Ames HCV. 
Table 18 (Continued) 
Day 
Isolate SIT (pig) Source of samples Clinical Tempera- Leukocyte FATCT resultsc 
number number infection obtained3 reactionb tu re count Blood Feces Saliva 
331 8385 Specimen 331 73 None 104,2 •••• + • ••• t t I t 
85 Slight 105,2 31,400 + + + 
8498 Exposure to 9 Slight 105,0 6,450 + •••• • ••• 
pig 8385 20 Slight 103,4 4,550 + I I I I •••• 
30 Slight 104.4 12,400 + • • • • •••• 
41 Slight 105,8 24,750 + • • • • •••• 
8537 Exposure to 10 Slight 106.6 2,100 + • • • • •••• 
pig 8498 21 Slight 104.6 3,750 + •••• • ••• 
°' 00 
~ · 
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observed clinical reaction did not always correspond to that which might 
have been expected from its temperature and leukocyte count. 
Field Case Histories 
The large ntmlber of HCV's classified as immunizing was somewhat 
unexpected. Particularly since the experimentally infected pigs were 
highly susceptible to HC. Were these isolates "naturally occurring" 
or was there some other possible source of infection , e . g ., recent 
vaccination with modified-live HCV (MLV)? The histories which accompanied 
1 
specimens from which I viruses were isolated are presented in Table 19. 
2 
Those from which I viruses were isolated are presented in Table 20. In 
many instances pigs had been recently vaccinated or treated with MLV prior 
·;_ 
to obtaining samples . However, in other instances, there was no indication 
of the introduction of MLV into the herd. 
Interpretation of Swine Inoculation Tests 
It was possible to interpret most of the SIT's in a straight-forward 
manner. However, a few of the tests presented some difficulties. 
A sewage line stoppage resulted in the partial flooding of isolation 
cages containing pigs injected with FATCT-negative specimens 112 and 114. 
The sewage contained excreta from HCV infected pigs. Both of the test pigs 
involved were sick when blood samples were obtained several days following 
the accident. 
The blood sample from the first pig inj ected with specimen 112 was 
FATCT negative. Since any final SIT result would have been clouded by the 
Table 19. 1 History and remarks pertaining to field cases from which I HCV's were isolated 
Case 
number 
6 
10 
Treatment prior 
to obtaining 
samples Additional history and remarks 
a 
Serum Vaccinated 16 days prior to outbreak with MLV without serum. 
Serum and MLV No additional information. 
24 hrs before 
samples were 
obtained 
39-51 Serum and MLV First clinical signs on 9-2-63. Treated 9-3-63. Several large hogs 
died about 9-15-63. 
49 Serum, 
penicillin and 
streptomycin 
One hundred and forty-seven suckling pigs sick 3 weeks ago. 
Weaned and then got sick again. 
Recovered. 
58 No infonnation Twenty-six, 2-week-old pigs sick. Farrowed by 4 sows given serum 
71 Serum and MLV 
2 days before 
samples were 
obtained 
alone about 3 months ago. 
Thirty pigs purchased from sales barn 5 weeks ago. Mixed with 121 pigs 
which had been recently vaccinated. 
a 
Anti-HC serum unless otherwise specified. 
~· 
Table 19 (Continued) 
Case 
number 
90 
Treatment prior 
to obtaining 
samples 
Sulfa, 
liquemycin, 
penicillin, 
streptomycin 
erysipelas 
serum 
Additional history and remarks 
No vaccination on this farm since the last HC outbreak, 25 years ago. 
No pigs added to the herd for some time. Pigs were sick for 2 weeks 
before lesions suggestive of HC were observed. 
145 No information Vaccinated with MLV about 2 weeks ago. 
146 No infonnation Both sows and their pigs sick. Typical lesions of HC . 
162 No information Feeder pigs supposed to have been vaccinated 1-20-64 . Purchased 
232 
1-21-64, sick 1-27-64. Leucopenia and lesions of HC. 
No information First sick 3-21-64. Samples received 3-26-64. 
on heart, kidney and bladder, gastroenteritis. 
PnelDllonia, petechiae 
Temperatures 98-104 F. 
261 No information Typical HC lesions and symptoms. 
275 
333 
342 
None 
Some pigs 
treated with 
serum and MLV 
Sertun 
No t vaccinated. Typical HC lesions. 
Spleens from 3 pigs. One had been treated with MLV and serum, 2 had 
not been treated. (Two of the 3 spleens were FATCT positive .) 
Continuous farrowing system practiced on this farm. Pigs are vacci-
nated shortly after weaning. Last group vaccinated 3-1-64 . All 
sickness in suckling pigs under 2 weeks of age . First observed sick 
on 3-22-64. 
Table 20. History and remarks pertaining to field cases from which r 2 HCV's were isolated 
Treatment prior 
Case to obtaining 
number samples Additional history and remarks 
8 None Recently vaccinated with ~fLV without serlllll . a 
18-19-20 No information No information. 
22-44 Serum Not vaccinated. Sows became ill in late gestation and were given 
only sertun. Specimen 22 from a sow. Specimen 22 received 8-1- 63. 
Pigs farrowed by these sows became ill at about 5 weeks of age 
(9-9-63). Specimen, 44 was a spleen from 1 of the pigs (r2 HCV 
from both specimens). 
54-56 Serum and MLV 
87 Serum and MLV 
91 None 
104 Serum and 
antibiotics 
109 Neomycin and 
terramycin 
117 Sulfathiazole, 
furacin and 
antibiotics 
a Anti- HC sertun. 
No information. 
Typical HC, symptoms and lesions. 
Not vaccinated. Typical lesions of HC . 
Some of the pigs vaccinated 2 weeks ago with MLV without serum. 
Typical HC lesions. 
Samples from 6-week-old pig not vaccinated. Lesions suggestive 
of HC. 
Vaccinated 12-12-63 . Samples received 12- 20-63. A statement was 
made in the history that this appears to be a recurring condition 
associated with a continuous farrowing system. 
Table 20 (Continued) 
Case 
number 
158 
171 
173 
181 
183 
186 
207 
214 
222 
240 
Treatment prior 
to obtaining 
samples Additional history and remarks 
No information Sample from 5-week-old pig. Some of the sows were vaccinated 
with MLV about 3 weeks before farrowing. Pigs born hairless. 
Live pigs anemic and icteric. No typical RC lesions. 
No information 
No infonnation 
No information 
Serum 
No information 
None 
None 
Serum 
No information 
Vaccinated. No statement as to when pigs were vaccinated. 
Not vaccinated. Clinical signs not typical of HC but lesions 
suggest HC. 
Petechiae on kidney. Anemic. 
Not vaccinated. 
Some pigs vaccinated twice with MLV and serum. Last vaccination 
2 weeks ago. Leucopenia in 7 of 8 pigs. 
Not vaccinated. Petechiae on kidney, bladder, and lungs. 
Part of the herd was vaccinated on 1-24-64 with MLV and serum. 
Samples from 3-week-old pigs received on 3-18-64. Typical 
lesions of HC. Leucopenia 400-5,000 WBC's/nm3. 
Not vaccinated. Petechiae on kidneys, necrotic tonsils. 
Not vaccinated. Pigs die suddenly. Temperatures about 103 F. 
Petechiae on kidneys. Lesions of pneumonia. Clinical diagnosis 
of enterotoxemia. 
,:. 
Table 20 (Continued) 
Case 
number 
262 
289 
311 
314 
316 
Treatment prior 
to obtaining 
samples Additional history and remarks 
No information Leukocyte counts on 2 pigs, 5,720 and 1,672 WBC's/nun3. 
Antibiotics Illness in group of baby pigs 1-2 weeks old. One sow slightly 
ill. No lesions suggestive of HC in pigs autopsied on the farm, 
but petechiae observed on the kidneys of l pig sent to the Iowa 
State University Diagnostic Laboratory. Sows vaccinated 2 years 
ago. No pigs vaccinated on the farm during the last 4 months. 
Two months ago, 6 sows farrowed 40 pigs. The pigs went through 
the same type of illness. Twenty-nine of the pigs died. 
Penicillin and 
streptomycin 
None 
Serum and MLV 
24 hrs before 
obtaining 
samples 
Not vaccinated. Illness in pigs about 8 weeks old. Leukocyte 
counts on 3 pigs, 14,550, 10,200 and 4,550/mm3. Clinical signs: 
high temperature, constipation, anorexia and ataxia. Lesions: 
hemorrage of kidneys, bladder, lungs , and gastric serosa, 
marginal hyperemia of lymph nodes. 
Illness in group of 50 pigs, 8 weeks old, not vaccinated. 
However, the first animal that died was a sow recently purchased 
at a sale barn. Temperatures from 104-105.5 F. Only lesions 
suggestive of HC were petechiae on the kidneys. All pigs have 
pneumonia. 
Illness in group of 8-week-old pigs. Not vaccinated. Temperatures 
104-106 F. Clinical signs: Loss of appetite and diarrhea. 
Lesions: serous and hemorrhagic lymphadenitis, petechiae in 
rnedullary area of kidneys, widened costochondral junctions of ribs 
and catarral to necrotic enteritis. 
Table 20 (Continued) 
Case 
number 
322 
323 
328 
335 
337 
Treatment prior 
to obtaining 
samples Additional history and remarks 
No information Samples from pig 4 months old. Vaccinated. Recently purchased at a 
sale barn. Average temperatures of pigs, 106 F. Clinical signs and 
lesions of HC. 
None Ten of eighty, 125-225 lb pigs are sick, Eleven have died. None 
have been vaccinated. Temperatures up to 107.5 F. Clinical signs: 
depression, anorexia and respiratory symptoms. Lesions: petechiae 
on kidney, bladder and larynx. 
No information 
Tylosin in 
drinking water 
No information 
Vaccinated 10 days ago with MLV without serum. Lesions: wide 
costochondral junctions, petechia in kidneys and serous 
lymphadenitis. 
Sample from 3-month-old pig, Pigs recently purchased from various 
sources . Clinical signs: diarrhea, staggered gait. Lesions: 
severe inflammation of stomach, massive pneumonic areas of entire 
lung, enlarged spleen, urinary bladder normal, mesenteric lymph 
nodes peripheral hemorrhage , and marked hemorrhage of serosal surface 
of intestines. 
Illness in group of 80 pigs, 2 months old. 
Clinical signs: diarrhea and staggering, 
Vaccinated 2 weeks ago. 
Temperatures 105-107 F, 
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prior history of contamination, the pig was killed 2 weeks after receiving 
the field specimen. At autopsy the pig did not have lesions indicative of 
HC. Eleven days after injection of the first pig, inoculum was again 
prepared from specimen 112 and injected into a second pig. This pig died 
4 days later. There were no typical lesions of HC and the spleen was FATCT 
negative. Eight months later a third pig was injected with specimen 112. 
~ 
This SIT was negative. The conclusion was that HCV was not present in the 
specimen. 
The field case history which accompan~ed specimen 112 lent some 
support to the above conclusion. The pigs had diarrhea, elevated 
temperatures and were sneezing. They had swine pox. Lesions were those 
of pneumonia and catarral enteritis. One week before the specimen was 
obtained, MLV and anti-RC serum had been administered to the herd. 
The blood sample from the first pig injected with specimen 114 was 
FATCT positive. The pig died shortly after the blood sample had been 
obtained. Approximately 10 days after specimen 114 had been received, 
another specimen (specimen 120) was submitted from the same herd. Three 
ml of inoculum prepared from specimen 114 and 3 ml of inoculum prepared 
from specimen 120 were pooled and injected into a second pig. This SIT 
was negative. Eight months later a third pig was injected with specimen 
114. This test was also negative. The conclusion was that the first pig 
injected with specimen 114 was infected with HCV by accidental exposure 
to contaminated sewage and that the specimen did not contain HCV. 
A rather complete history accompanied specimens 114 and 120. The 
course of illness observed was t hat 1 or more pigs in a pen developed 
77-79 
anorexia and lethargy which persisted for 1-7 days. Temperatures were 
usually normal with an occasional high of 104 F. Within 3-7 days after 
the first clinical illness, pigs developed a severe hemorrhagic diarrhea 
and died within 8 hrs. Leukocyte counts were normal to slightly elevated 
and lesions were confined to the gastrointestinal tract. 
The SIT results with specimens from cases 112 and 114-120 have been ~ 
presented in considerable detail for 2 reasons. First, because they 
caused some difficulty in interpretation, but in addition, these were the 
only instances when pigs died after receiving a field specimen and the 
overall SIT result was recorded as negative. 
Specimen 57 was too decomposed to examine by the FATCT; however, it 
was injected into a pig. The pig was clinically normal for 9 days after 
receiving the field specimen, but on the tenth and eleventh days it had a 
slight reaction and it died on the twelfth day. Samples were not obtained 
for FATCT examination. Gross lesions were not suggestive of HC. Since 
this specimen could not be used to satisfy the primary objective of this 
study, i.e., to compare FATCT and SIT results with field specimens, no 
additional SIT's were done. No conclusion was reached as to whether the 
specimen was SIT positive or negative; thus, for all practical purposes, 
it was treated as if it had not been examined by either the FATCT or the 
SIT. 
Interesting results were obtained with the specimens from case 39-51. 
Specimen 39 was a blood sample and 51 was a spleen. Both were FATCT 
negative. 
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One of 2 blood samples taken from the pig injected with specimen 39 
was FATCT positive. Following an obvious clinical reaction, the pig 
recovered and was challenged on 10-6-63. Temperatures taken on the first 
3 days following challenge were all 102. 8 F. No additional temperatures 
were taken but the pig continued to appear clinically normal. Sixteen days 
after challenge the pig was "released" from the experiment and the SIT- was 
recorded as positive. The field isolate was classified as r1 • After its 
release the pig was placed in an isolation room with other pigs which had 
also resisted challenge. Without showing a·ny prior clinical signs, the 
pig died on either the evening of 11-5-63 or early morning of 11-6-63. 
Some of the lesions observed at autopsy were suggestive of RC. 
Two blood samples were taken from the pig injected with specimen 51. 
One was FATCT positive. The pig was sick for 27 days prior to its recovery 
and subsequent challenge. It died 3 days after challenge. One year later 
another pig was injected with specimen 51. It had a slight clinical 
reaction on the sixth, eighth, ninth and tenth days after receiving the 
specimen. No blood samples were taken from this pig. Twenty-four days 
after receiving the specimen, the pig was challenged . It died 10 days 
later. 
Case 39-51 was recorded as FATCT negative and SIT positive. 
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CORRELATION OF FLUORESCENT ANTIBODY-TISSUE CULTURE 
AND SWINE INOCULATION TEST RESULTS 
All 225 FATCT-positive diagnoses of HC were confirmed by SIT's. On 
the other hand, there were 8 cases of HC from which HCV was detected by 
SIT's but not by FATCT's done with the same field specimens. Eighty- three 
suspected cases were negative by both tests (Table 21). Results could not 
be compared for the remaining 22 cases because 1 or both tests were not 
done or the SIT was considered questionable (Table 22). 
The majority of the 238 cases for which a laboratory diagnosis of HC 
was made, were confirmed in 3 ways. First, HCV was identified from the 
field specimen by the FATCT. Secondly, the disease was reproduced in a 
clinical or subclinical form and thirdly, HCV was reisolated and identified 
by the FATCT from the blood or spleen of the experimentally infected pig 
(Table 23). 
A comparison was made between the relative virulence of field 
isolates of HCV and the frequency of their isolation and subsequent 
identification by the FATCT (Table 24). A comparison was also made 
between the relative virulence of field isolates and their titer in the 
field samples from which they were isolated (Table 25). The samples 
represented in Table 25 are the same as those in the previous Tables 3, 
4, 5, 6 and 7. Not all the FATCT-positive samples are represented since 
the titer estimate was not initiated until sometime after this study had 
begun. 
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Table 21. Correlation of SIT and FATCT results on 316 suspected cases 
of RC 
Ntnnber Test 
of cases SIT 
225 Positive 
8 Positive 
83 Negative 
results 
FATCT 
Positive 
Negative 
Negative 
% 
correlation 
96.6 
100 
Table 22. St.nnmary of SIT and FATCT results on 22 suspected cases of 
RC for which no correlation could be made 
Number 
of cases 
5 
3 
6 
8 
Test results 
SIT 
Positive 
Negative 
Questionable 
b 
•••• 
FAT CT 
a 
•••• 
a 
•••• 
Negative 
a 
• ••• 
a 
Samples decomposed or adulterated to the extent that no FATCT 
could be performed. 
b 
Samples from these 8 cases were severely decomposed and no SIT 
was performed. 
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Table 23. Correlation of positive SIT results with FATCT results on 
field specimens and samples taken from experimentally 
infected pigs 
Number SIT results FATCT results 
of cases Field specimens Field specimens Lab sarnoles 
203 Positive Positive Positive 
17 Positive Positive Negative 
5 Positive Positive a .... 
8 Positive Negative b Positive 
5 Positive c Positive •••• 
Total 238 
~o samples taken. 
b In 2 instances a blood sample from the experimentally infected 
pig was FATCT negative but HCV was isolated and identified by FATCT 
from the spleen. 
c Decomposed or adulterated specimens, no FATCT done. 
·.<.. 
Table 24. Comparison of the relative virulence of HCV's and the frequency of their isolation 
and identification by FATCT 
Field samples Blood samples from 
HCV Number Spleen Blood experimentally infected pigs 
classification of cases Number % :eositive Numb et % 12ositive Number % 12ositive 
Lethal 193a 267/29lb 91.8 142/219 64.8 198/203 97.5 
Irmnunizing 45 57/67 85.1 36/73 49.3 27/52 51.9 
Total 238 324/358 90.5 178/292 61.0 225c/255 88.2 
afield isolates from 193 cases killed experimentally infected pigs. 
b Numerator a number FATCT positive; denominator• number examined by FATCT. 
~oes not include 13 FATCT positive blood samples from pigs e~posed by contact (Tables 17 
and 18), injected with specimens from cases considered questionab.le (Table 14) • and the first 
pig injected with specimen 114. 
~· 
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Table 25. Comparison of the relative virulence of HCV's and their 
titer in the field samples from which they were isolated 
Virus 
classification 
Lethal 
Immunizing 
Total 
Type of 
sample 
Spleen 
Blood 
Spleen 
Blood 
Spleen 
Blood 
Number of 
samples 
230 
115 
46 
31 
276 
146 
Average HCV 
titer/samplea 
3.5 x 104 
2.5 x 104 
1. 7 x 104 
1. 7 x 104 
3.1 x 10
4 
2.4 x 104 
Average numerical 
value/samplea 
3.8 
2.9 
3.1 
2.7 
3.7 
2.9 
3The methods for estimating the HCV titer and for calculating the 
average titer and numerical value are presented in PART I. FLUORESCENT 
ANTIBODY-TISSUE CULTURE TEST. 
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DISCUSSION 
A close correlation was found between the results of SIT's and 
FATCT's, however, several advantages were noted for each type of test. 
Foremost is the fact that swine inoculation is a more sensitive method 
to detect HCV. Excluding the questionable cases, virus was detected 
from 8 cases only by SIT's. Another advantage of swine inoculation ls 
that samples which are too decomposed or adulterated to be run by the 
FATCT, can be tested in swine. 
On the other hand, there are several disadvantages of SIT's which 
more than offset the advantages. First is the expenditure that is 
necessary, not only for swine but also for the elaborate isolation 
facilities that are required. Secondly, the time factor must be con-
sidered. A significant number of SIT's required several weeks or even 
months to complete; in contrast, the FATCT was usually completed in 
16-24 hrs. Of course, the disadvantages of swine inoculation discussed 
thus far were not uniquely revealed by this study. They are well known 
and have been stated elsewhere (62). However, 1 disadvantage of SIT's 
was emphasized during this study and that is the lack of clear-cut 
results which can occur in some instances. For example, if a pig is 
infected with a HCV of low virulence, the ensuing reaction is, to say 
the least, confusing. In addition, false negative results can occur. 
To exemplify this point, let us take a specific example. A blood sample 
was submitted from suspected case 158. The history gave little reason 
to believe that this was a case of HC, or so it was believed at the time. 
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Pigs 4-5 weeks of age were anemic and icteric. Some had been born 
hairless. The sample was examined by the FATCT and was found to contain 
a high titer of HCV. In the meantime the remainder of the sample, 3 ml, 
had been injected into a RC-susceptible pig. Following the injection, 
the pig had no definite clinical reaction. On the seventh day it was 
bled and HCV was again identified by the FATCT. Its temperature on the 
day of bleeding was 102.6 F. Since the pig had had no clinical reaction, 
it was challenged 14 days after receiving the field sample. It died 6 
days later. The above infonnation was then reported to the person who 
had submitted the sample. At that time an additional bit of infonnation 
was received. Since HC had been diagnosed on the neighboring farm, the 
sows of the herd in question were vaccinated in the latter third of 
gestation. The original ·field sample had been used up for the FATCT and 
the first SIT; therefore, 2 additional pigs were injected with a blood 
sample from the pig previously injected with the field sample. Both of 
these pigs were found immune when subsequently challenged (Tables 13 and 
15). 
The few negative SIT results with specimens previously shown to 
contain HCV, cannot be particularily emphasized because the SIT ~~as not 
employed to its fullest advantage. Ideally, both RC-susceptible and HC-
immune pigs would be injected with the same suspect tissues (62). Also, 
at least 1 RC-susceptible pig should be injected with the suspect tissue 
plus anti-RC serum. Sufficient isolation facilities were not available 
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for performing all tests in such an elaborate manner. As it was, over 
400 pigs were used in this study. 
Concisely, what are the general attributes of the FATCT? There is 
no doubt that the FATCT is highly reliable, especially if certain 
procedures are followed, including the selection of samples. These 
procedures will be discussed subsequently. In addition, the FATCT is ~ 
relatively economical, rapid, and easy to read. 
Before reaching a conclusion about the percentage of field cases 
of HC from which virus was identified by the FATCT (such as the 96.67. 
in Table 21), 2 other factors must be considered. Both tests may have 
failed to detect HCV in suspect tissues. Furthermore, tissue may have 
been obtained from swine which were not infected with HCV even though 
other swine in the same herd were infected. 
The correlation of results presented in Table 21 was made on a 
case basis. If it had been made on a specimen basis, the overall 
correlation would have been altered slightly. In 2 instances when 2 
specimens were submitted from the same field case, both were positive 
by SIT's, whereas, only l of 2 was positive by FATCT's. 
The success of the FATCT for the detection of HCV is contingent 
upon 3 factors: (1) a standardized and specific fluorescent antibody 
preparation, (2) HGV-susceptible, uniform cell cultures, and (3) 
satisfactory tissue samples from suspected cases of HC. 
No difficulties should be encountered in preparing satisfactory 
fluorescent antibody, providing the elements responsible for non-
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specific staining are effectively removed. Rabbit liver powder "sorption" 
has been satisfactory for this purpose. Once the fluorescent antibody is 
prepared it may be stored for a prolonged period at -60 c. One such 
preparation has been maintained at the NADL for over 2 years without a 
significant decrease in potency. 
The best results are obtained with PK-15 cells if they are used fo~ ~ 
the FATCT within 3-4 days after they have formed a confluent monolayer. 
As these cells age, the specific staining decreases and the nonspecific 
staining increases. In addition, the cells continue to multiply, forming 
a multilayer of cell growth on the coverslip. This multilayer tends to 
"trap" the fluorescent antibody. As a result, there is an undesirable 
background of fluorescence which reduces the contrast between the specific 
staining of infected cells and the uninfected cells in the immediate 
vicinity. 
Sample quality is particularly critical. If cell cultures are exposed 
to inoculum prepared from tissues that have undergone marked decomposition, 
the cells are rapidly destroyed. Sufficient dilution of the inoculum to 
minimize this toxic effect also results in the undesirable reduction in 
virus content per unit volume of the inoculum. 
Multiple sampling is essential. Based on the information gained 
during this study, one can expect to isolate and identify HCV from 
approximately 90% of spleens obtained from swine herds where HC exists. 
Considering combined probabilities, there would be a 1 in 10 chance of 
obtaining a false negative result if only 1 spleen were submitted, 1 in 
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100 for 2 spleens. and 1 in l.OOO for 3 spleens. However. this reflects 
the average and probably does not accurately represent the reliability 
of the test for all cases of HC. More realistically• variabilities 
associated with each individual case should be considered. For instance. 
the treatment of swine with anti- RC serum could cause a significant 
reduction of the titer of HCV in the tissues and consequently decre~~e 
the chance for its detection by the FATCT. 
Spleen is markedly superior to blood as a diagnostic sample and 
therefore blood would be indicated primarily when spleen either is not 
available or when blood can be obtained from swine which appear to be 
in the acute stage of He. whereas. these same swine are not available 
for autopsy. A good rule of thumb is to submit the most samples from 
herds where the clinical findings are the most confusing. At least 3 
spleens should be submitted from any suspected case. 
Ideally, spleens should be obtained from swine with elevated 
temperatures and which are apparently in the acute stage of the disease. 
Less desirable but yet satisfactory samples could be taken from moribund 
swine or swine dead for only a short period of time prior to autopsy. 
In any case . the tissue should be shipped to the laboratory refrigerated 
or frozen to minimize decomposition in transit. 
Anticoagulants should not be added to blood samples unless it has 
been detennined that the anticoagulant or preservative contained therein 
is not toxic to cell cultures. The best procedure is to defibrinate the 
sample or allow it to clot and submit the serum. 
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A significantly greater percentage of blood samples from experi-
mentally infected pigs were FATCT positive than those from confirmed 
field cases of HC (Table 24). There are several probable explanations 
for this difference. The laboratory samples were from pigs known to 
be infected with HCV, whereas, some of the field samples may have been 
taken from pigs not affected with HC. The majority of the experimentally. ~ 
infected pigs were bled during a period of marked clinical illness. This 
may not have been true for as many of the field samples. Hog cholera 
virus may have been destroyed by the decomposition of some of the field 
samples. Finally, many of the swine from which field samples were obtained 
had previously been treated with anti-RC serum. 
It is also obvious from Table 24 that lethal HCV's were isolated much 
more frequently from the blood stream of experimentally infected pigs than 
were immunizing viruses. A lesser difference occurred between the blood 
samples from pigs naturally infected with these types of viruses. This 
discrepancy can logically be explained by assuming that the viruses 
classified as immunizing were causing a more severe reaction in the field. 
This assumption is confirmed by field case histories (Tables 19 and 20). 
The FATCT could not be used to differentiate between lethal and 
immunizing field isolates of HCV. Even though less virus was present in 
tissues of swine naturally infected with HCV's classified as immunizing, 
this difference was not particularly striking (Table 25). Considering an 
individual case from which only a few samples might be submitted, it is 
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doubtful if any reliable determination of virulence could be based on 
the virus content of tissues. 
The relative virulence of a particular HCV usually is of little 
significance in the field. The important factor is, of course, the 
severity of the disease it is able to cause under the particular field 
conditions in which it occurs. However, the inability to dete~ine~ 
relative virulence by the FATCT brings out an important practical 
consideration. If samples are obtained from swine which have been 
recently vaccinated or treated with MLV, care must be exercised in 
drawing a conclusion from a positive test. The virus isolated and 
identified may not be responsible for clinical HC. In fact, irrespective 
of the circ\..Uil.stances, it should be emphasized that the FATCT detects the 
presence of HCV; it does not actually diagnose HC. The FATCT results 
plus additional laboratory and field information should be used in 
arriving at a diagnosis of the disease. 
From the laboratory standpoint, the FATCT can most advantageously 
be used in conjunction with other types of tests which are based on 
evidence of the disease itself. For example, leukocyte counts and 
histopathologic examinations would yield valuable information which 
could be correlated with FATCT results. 
The virulence classification of field isolates of HCV provided a 
general view of the relative virulence of naturally occurring HCV's . 
The application of the same method of classification to the reactions 
of pigs challenged with Ames HCV provided a base line of virulence to 
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which field isolates could be compared. The 2 major divisions of the 
1 classification scheme, i.e. lethal and innnunizing, were of course 
fundamental, but the subclassifications were made somewhat arbitrarily 
1 
except for L • When it was found that most of the pigs challenged 
with Ames HCV died after a clinical illness of 10 days or less, this 
subclassification was made in retrospect. 
Lethal viruses were subclassified by the days of c linical illness 
preceding death rather than by the total days from exposure to death 
for 2 reasons. Many of the samples had undergone various degrees of 
decomposition and as a consequence the virus contained therein may 
have been attenuated slightly. In addition, the amount of virus each 
pig received varied with the HCV titer of the sample(s) from which 
the inoculwn was prepared. It was assumed that if these factors did 
affect SIT results, they would be reflected more by the incubation 
period than by the duration of clinical illness. 
Since the reaction of a pig to HCV infection depends on its innate 
resistance as well as the pathogenicity of the virus, it is probable 
that other types of pigs would have reacted differently to some of the 
field isolates. However, for the determination of relative virulence, 
it is believed that the classification data is generally reliable. 
A few statements can, therefore, be made about the virulence of 
the 238 naturally-occurring HCV 1 s which were isolated during this 
study. Approximately 30% of them were as virulent as Ames HCV, that 
1 is, they were classified as L • Approximately another 20% were classified 
--
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as immunizing and the remainder somewhere between these· 2 extremes. There 
is 1 adjustment that could appropriate~y be made in the above figures. 
Upon examination of Table 11, it will be noted that a significantly lesser 
percentage of immunizing viruses were submitted by the Animal Health 
Division. To explain this difference it is necessary to divide the term 
..... 
of suspected cases into "3 degrees of suspected". Samples were received 
from cases which were probably HC, from cases which were possibly HC and 
from a few cases which were probably not HC. Samples submitted by the 
Animal Health Division were more frequently from cases in the first 
category above or in other words "selected cases" wherein the signs and 
lesions observed were typical of HC. 
This difference is also reflected by the percentage of laboratory 
confirmed cases from the various sources (Table 10). It would be expected 
that highly virulent HCV's would cause the more typical clinical 
manifestation. Then to obtain a more representative overall picture of 
the virulence of naturally-occurring HCV's, one may consider only those 
isolates submitted by veterinary practitioners and the Iowa State 
University Veterinary Diagnostic Laboratory. Thus, it is found that over 
30% of these field isolates were classified as immunizing . 
Certainly few, if any , of the immunizing viruses would have been so 
classified on the basis of the r eactions of naturally-infected pigs. 
Therefore, probably none of the viruses isolated during th i s study can be 
considered as avirulent and possibly all are potentially lethal under the 
appropriate circumstances. 
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More than 1 SIT was done with many of the field specimens. The 
various reasons for repeating tests have already been pointed out. 
Occasionally the time between the first and subsequent tests was over 
a year. This interval was not by design but occurred because the 
isolation facilities were usually fully utilized for a single SIT for 
each specimen at the time it was received. Consequently, the majority ~ 
of the repeated tests were done when additional specimens were no longer 
being submitted from the field. During the time between the first and 
subsequent tests, specimens were stored at -60 c. However, most of the 
specimens were thawed or partially thawed once during their storage in 
the process of transferring them from one freezer to another. Therefore, 
most of the repeated tests were done with specimens that had been frozen 
and thawed twice (or 3 times if the specimen had been frozen for shipment 
to the NADL). 
A SIT diagnosis of HC was considered questionable on 6 suspected 
cases because of the contradictory results of SIT's done for these cases. 
The specimens were all FATCT negative. Except for specimen 53, the first 
SIT done with each of them was positive, whereas repeated SIT's were 
negative. The first SIT with specimen 53 was considered incomplete, a 
second test was positive, and a third test was negative. Results of the 
individual SIT's and additional information pertaining to them have been 
presented in Table 14. There are several possible explanations for the 
contradictory results. 
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If it is assumed that these specimens did contain HCV, then it may 
also be asswned that they contained a minimal amount of virus. Since 
the FATCT was negative it seems reasonable that if virus was present, it 
was present in a low concentration . Therefore, repeated tests may have 
been negative because the small amount of viable virus was destroyed 
during storage of the specimen. It is also possible that the first . ~ 
inoculum contained a few infectious units of HCV, whereas, by chance, 
the inoculum that was subsequently prepared from the same specimen, did 
not contain infectious HCV. 
If it is assumed that the specimens did not contain HCV, then what 
was the source of the virus which caused the positive SIT 1s? The test 
pigs may have been inadvertently exposed to HCV, possibly before they 
were placed in the isolation cages or in 1 instance, specimen 47, at the 
time of bleeding (Table 14). Another possibility is that the inoculum may 
have been contaminated with HCV during its preparation in the laboratory. 
It is probable that a minimal contamination would more likely be detected 
by the SIT than by the FATCT. 
Any of the possibilities mentioned above could apply to 1 or more of 
the 6 cases. However, since no definite conclusion could be reached, 
these cases remain questionable. 
Field isolates 109, 158, 219, 300, 331 and 342 failed to either kill 
or immunize the first pig injected with each of them. The corresponding 
specimens and consequently the suspected field cases would have been 
recorded as negative if HCV had not been identified by the FATCT from the 
97 
field specimens and the blood samples from 5 of the 6 test pigs . The 
knowl edge that the specimens contained HCV prompted repeated SIT' s with 
them. The repeated tests were all positive (Table 15). Since the 
repeated tests were positive, it appears that the first pigs may have 
failed to resist challenge with Ames HCV because they were incapable of 
a "normal" immunologic response. However, in at least l instance the 
pig failed to resist challenge for another reason . 
Pig 8105 was challenged 27 days after it had been injected with 
isolate 300. The pig was slightly ill for 2 periods following injection 
of the isolate, once for 6 days and once for 7 days, but had been 
clinically normal for 8 days prior to challenge. Just prior t o challenge 
a blood sample was taken. On the same day the pig ' s temperature was 
102 . 2 F. t'1hen the pig died following challenge, the blood sample was 
examined by the FATCT and was found to contain HCV. It was , therefore, 
obvious that the pig had only apparently recovered and was challenged 
at a time when it still had a viremia from infection with isolate 300. 
The second pig injected with isolate 300, pig 8376, was not challenged . 
It died 104 days after it had received the field isolate (Table 16). 
Blood samples were not obtained from the other pigs just prior to 
challenge . However, a similar situation may have occurred in at least 
1 other instance. Pig 8148 , which had been injected with isolate 331 , 
had a reaction but apparently recovered and was challenged. It died 
following challenge. The second pig injected with isolate 331 was not 
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challenged . It died 100 days after it had been injected with the field 
isolate (Table 16). 
Occasionally more than 1 specimen was submitted from the same field 
case but from different sources and/or on different days. If the 
accompanying information did not clearly indicate their common origin, 
the specimens were initially assumed to have come from different cases. 
Only after obtaining some additional information or after some additional 
"detective work" was it possible to correctly associate these specimens 
with the appropriate cases. 
A similar problem occurred when more than 1 blood sample or several 
pieces of spleen were submitted from the same herd and there was no 
information to indicate whether the samples were from the same or different 
pigs. 
The above problems occurred infrequently. Neverthe less they are 
stated as a point of information and to explain the reason for a slight 
difference between the results presented in this thesis and those 
presented in a brief preliminary report of these studies (66) . Addi tional 
information and study of the data neces si tated these minor changes. 
In a few instances a choice had to be made for the purpose of 
recording the source of specimens from a suspected case of HC . For 
example, specimens 18, 19 and 20 were from the same case but specimens 
18 and 19 were referred by the Iowa Stat e University Veterinary Diagnostic 
Laboratory whereas specimen 20 was submitted directly to the NADL by a 
veterinary practitioner. In Tables 10 and 11, this case is listed for 
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the Iowa State University Veterinary Diagnostic Laboratory. In addition, 
a few specimens were apparently collected by veterinary practitioners but 
reached the NADL by an indirect route. These specimens were recorded as 
if they had been sent directly to the NADL by the practitioner . The 
previous statement, of course, does not apply to the specimens referred 
by the Iowa State University Veterinary Diagnostic Laboratory. 
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SUMMARY 
An extensive evaluation of the fluorescent antibody-tissue culture 
test (FATCT) was conducted to determine its efficacy as a routine 
diagnostic test for hog cholera (HC). Tissues submitted from suspected 
or possible cases of HC were examined by the FATCT. Results thus 
obtained were compared to those obtained by the inoculation of HC-
susceptib le swine with a portion of the same tissues. 
-... 
Spleen and blood samples were received from 338 sus pected cases of 
HC occurring in 22 states. It was possible to compare the results of 
the FATCT and the swine inoculation test (SIT) for 316 of these cases. 
Hog cholera virus (HCV) was identified by the FATCT from 1 or more 
tissues from 225 cases. These positive FATCT results were confirmed 
by SIT's . Hog cholera virus was identified from 8 cases by SIT 1 s but 
not by the corresponding FATCT's. Both types of tests were negative 
for 83 suspected cases. 
A comparison of results could not be made for the remaining 22 
cases from which samples were received. Tissues from these cases were 
either too decomposed or adulterated to examine by the FATCT or the SIT 
results were considered questionable. 
A total of 918 spleen and blood samples were received from the 
above 338 suspected cases of HC. Sixty-eight of the samples were too 
decomposed or adulterated to examine by the FATCT. Hog cholera virus 
was identified by the FATCT from 502 (59%) of t he remaining 850 samples . 
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Spleen was superior to blood as a diagnostic sample. Three hundred and 
fifty-eight spleens were submitted from swine herds wherein HC was 
proven to exist by the SIT. Hog cholera virus was identified by the 
FATCT from 324 (91%) of these spleen samples. In contrast, only 178 
(61%) of 292 blood samples from these same herds were FATCT positive. 
The majority of the HCV's which were isolated during this study 
killed experimentally infected pigs and were consequently classified 
as lethal. However, approximate l y 20% of the field isolates were of 
lesser virulence. That is, they immunized experimentally infected pigs 
agains t subsequent challenge with the lethal Ames strain of HCV. 
The close correlation that was found between the results of FATCT 's 
and SIT's should stimulate the acceptance of the FATCT as an .tq vitro 
method to identify HCV from naturally-occurring cases of HC. 
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APPENDIX A 
Preparation of Carbonate-Bicarbonate Buffer (64) 
Solution A - Na2co3 - 5.3 gm 
H20 to make 100.0 ml 
Solution B - NaHC0
3 
- 4 . 2 gm 
H2o to make 100.0 ml 
A pH of 9 . 0 should result from mixing 4.4 ml of solution A with 
100 ml of solution B. However, it is sometimes necessary to add more 
of solution A to the mixture. The pH should be checked on a meter . 
Preoaration of Rabbit Liver Powder 
1. Remove the omentum and gall bladders from fresh rabbit livers. 
2. Homogenize the livers in a mechanical blender by short 
repeated activations of the blender to prevent overheating. 
3. Extract the homogenized liver by washing it 3 x in 4 x its 
volume of acetone. After each washing , allow the liver to settle and 
then decant the supernatant fluid. 
4. Collect the washed liver on a filter paper in a Buchner funnel. 
5. Dry the liver on the filter paper with suction until the acetone 
has evaporated. 
6. Break up the cake of liver that has formed on the filter paper 
and allow it to continue drying overnight at 37 c. 
7. Finely divide the dried liver to a powder by homogenization in 
a blender. 
·i.. 
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APPENDIX B 
Table 26. Individual FATCT and SIT results and virus classification 
FATCT results Virus 
Specimen 
number 
Field samples Lab samples SIT classi-
resultsb Spleen Blood Blood a fication 
1 l/lc 2/2 1/1 
2 1/1 0/1 1/2 
Not d examined ••• • 3 
4 0/1 0/2 • • • • 
5 1/1 0/2 1/1 
6 1/1 0/2 1/1 
7 •••• 1/1 3/3 
••• • 
~n most instances these blood samples 
mental pigs injected with field specimens. 
out in appropriate footnotes . For example, 
"u" • 
b + e positive; - s negative . 
+ 12 
+ 13 
Not examined e 
. ... 
+ 13 
+ Il 
+ 14 
+f 11 
were obtained from experi-
Exceptions will be pointed 
see the following footnote 
~umerator = number positive; denominator s number examined. 
Applies for both spleen and blood samples. 
d All the samples of the specimen were either decomposed and/or 
adulterated to the extent that no FATCT could be performed . 
e All the samples of the specimen were markedly decomposed and 
were not injected into a pig . 
£ 
Contact exposure. Not injected with specimen 7. Details pre-
sented in previous Table 17. Note here that when more than 1 SIT is 
associated with a particular specimen, the FATCT results with samples 
of that specimen are not repeated in the table. 
Table 26 (Continued) 
Specimen 
number 
8 
9 
10 
11 
12 
13 
14 
15 
16 
FATCT results 
Field samples 
Spleen Blood 
1/1 
O/lc 
•••• 
1/1 
1/1 
0/1 
0/1 
• • • • 
1/1 
0/1 
• • • • 
0/1 
0/1 
0/1 
1/4 
.... 
1/3 
• • • • 
0/2 
0/1 
2/4 
0/1 
• • • • 
•••• 
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Lab samples 
Blood a 
•••• 
0/1 
1/1 
1/1 
2/2 
• ••• 
•••• 
0/1 
1/2 
• • • • 
• • • • 
. ... 
0/1 
O/li 
• • • • 
SIT 
resultsb 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
• • • • 
Virus 
classi-
fication 
•••• 
•••• 
• ••• 
•••• 
•••• 
• ••• 
• • •• 
gSpecimen 18 included only lymph nodes which were FATCT negative . 
h From same suspected field case of HC as specimen 18. 
iPig killed 6 days after injection with specimen 19. The blood 
from this pig was FATCT negative but the spleen was FATCT positive . 
jlnj ected with blood from a pig injected with specimen 19. 
112 
Table 26 (Continued) 
FATCT r esults Virus 
Specimen Fiel d samples Lab samoles SIT classi-
number Spleen Blood Blood~ resultsb f ication 
20h •••• 0/1 . . . . • ••• 
21 Not examinedd 1/1 + 13 
•• • • + 14 . ..;. 
22 •••• 1/1 • ••• + !2 
23 0/1 • • • • • ••• •••• 
24 0/2c 0/1 1/1 + 12 
25 0/1 0/1 0/1 •••• 
26 0/1 •••• 0/1 • ••• 
27 0/1 •• • • 0/1 • ••• 
28 0/1 •••• 0/1 • ••• 
29 0/1 • ••• 0/1 • ••• 
30 Not examinedd 1/1 + 11 
31 0/1 0/1 0/1 ••• • 
32 0/1 0/4 0/1 •••• 
33 •••• 0/2 0/1 • ••• 
34 2/3 0/3 1/1 + Ll 
35 1/1 2/2 1/1 + 12 
36 .... l/3c 1/1 + Ll 
37 0/ 2 0/1 0/1 •••• 
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Table 26 (Continued) 
Specimen 
number 
38 
39 
40 
41 
42 
45 
46 
47 
FATCT results 
Fie ld samples Lab samples 
Spleen Blood Blood a 
1/1 
0/1 
0/3 
0/2 
2/2 
1/1 
0/1 
2/2 
1/1 
0/1 
•••• 
.. .. 
0/2 
.... 
•••• 
•••• 
.... 
2/2 
0/1 
0/1 
1/1 
1/2 
•••• 
• ••• 
1/1 
1/1 
0/1 
•••• 
1/1 
•••• 
1/1 
1/2 
.... 
SIT 
resultsb 
+ 
+ 
+ 
+ 
+ 
+ 
• ••• 
+ 
+ 
+ 
Virus 
classi-
fi cation 
• ••• 
• ••• 
• ••• 
•••• 
• ••• 
1l<il l ed in a moribund condition . Virus classified as lethal but 
not subclassified. 
l From same suspected field case of HC as specimen 22. 
11\>ig killed 6 days after injection with specimen 44. Blood FATCT 
negative, s pleen FATCT positive . 
°Pig died within 24 hrs after bleeding . No virus classification 
made on this SIT . The SIT was repeated for the purpose of virus 
classification. 
Table 26 (Continued) 
Specimen 
number 
49 
52 
53 
54 
55 
57 
FATCT results 
Field samples 
Spleen Blood 
• • • • 
1/1 
0/1 
0/1 
0/2 
• • • • 
.... 
1/1 
1/1 
0/1 
0/1 
• • • • 
0/1 
• • • • 
0/4 
0/3 
•• •• 
d Not examined 
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Lab samples 
Blood a 
• • • • 
1/1 
1/1 
1/2 
• • • • 
• • • • 
• • • • 
1/1 
• • • • 
•• •• 
1/1 
• • • • 
1/1 
• • • • 
SIT 
resultsb 
• • • • 
+ 
+ 
q 
• • • • 
+ 
+ 
+ 
+ 
s 
• • • • 
°From same suspected field case of HC as specimen 43 . 
PFrom same suspected field case of HC as specimen 39. 
Virus 
classi-
fi cation 
•••• 
•••• 
• ••• 
•••• 
•••• 
•••• 
• ••• 
•••• 
qSIT considered incomplete. Details presented in previous Table 
14 . 
r 
Fr om same suspected field case of HC as specimen 54 . 
s 
SIT considered incomplete . Details presented in previous t ext . 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SI T classi-
number S:eleen Blood Blood a resultsb fie at i on 
58 2/ 2 2/2 1/1 DBn •••• 
.... + Il 
59 0/2 0/3 . . . . .... 
60 0/ 1 0/1 . . . . •••• 
61 1/ 1 0/3 1/ 1 + KMk 
62 2/2 2/2 1/1 + Ll 
63 0/2 0/2 • • • • •••• 
64 3/3c 2/2 1/1 + KMk 
65 2/2 .... 1/1 + K}[k 
66 1/1 .... . ... + Ll 
67 1/1 1/1 1/1 + Ll 
68 0/1 0/1 0/1 •••• 
69 0/1 . . . . . ... ••• • 
70 2/2 2/2 1/1 + Ll 
71 2/2 0/1 1/1 + Il 
72 . . . . 0/1 . ... •••• 
73 1/1 1/1 1/1 DBn .... 
• •• • + Ll 
74 0/2 . . . . . . . . •••• 
75 0/1 0/1 . . . . •••• 
76 0/1 . . . . 0/1 •• •• 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blood a resultsb fic ation 
77 2/2 .... 1/1 + 11 
78 
. d 
Not examined . . . . .... 
79 0/1 0/1 • • • • •••• 
80 Not d examined • • • • •••• 
81 1/1 0/1 1/1 + ~ 
82 • • • • 0/1 0/1 •••• 
83 2/2c 1/1 t • • • • • • • • •••• 
•••• + 13 
84 1/1 4/4 1/1 + 11 
85 1/2 2/4 •••• + 11 
1/1 +u 11 
86 0/2 0/4 . . . . •••• 
87 1/1 1/3 0/2 + I2 
88 1/1 1/1 1/1 + 11 
89 0/2 .... 0/ 1 • ••• 
90 1/1 0/2 1/1 + Il 
91 2/3 1/3 1/1 + I2 
92 •••• 2/2 2/2 + 14 
tSIT conside red incomplete. Pig exs anguinated 27 days after 
injection with specimen 83. 
u 
Injected with blood from pig injected with s pecimen 85. 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
ntunber SEleen Blood Blooda resultsb fication 
93 1/1 5/5 1/1 + Ll 
94 Not . dd Not e examine •••• examined 
95 0/ 2 ... .... . ... . ... 
96 2/2 0/1 1/1 + KMk 
97 0/1 ... . • ••• • ••• 
98 1/1 1/1 1/1 + L2 
99 0/2 0/2 • • • • •••• 
100 2/4 1/2 1/1 + KMk 
101 • • • • 0/3c . ... •••• 
102 • • • • 0/3 • • • • •••• 
103 0/1 • • • • • ••• •••• 
104 1/1 0/1 1/1 + 12 
105 2/2 .... 1/1 + ~ 
106 2/2 2/2 1/1 + L2 
107v 0/1 0/1 . . . . •••• 
108 1/1 1/1 1/1 DBn •••• 
.... + Ll 
109 1/1 1/1 1/1 •••• 
.... + 12 
v From same suspected case of HC as specimen 102. 
Table 26 (Continued) 
Specimen 
number 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
FATCT results 
Field samples 
Spleen Blood 
1/1 
2/2 
0/2 
1/1 
0/1 
1/1 
0/lc 
1/1 
1/1 
1/2 
0/1 
.... 
2/2 
0/2 
•••• 
0/1 
•••• 
• • • • 
O/i 
•••• 
1/2 
. . . . 
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Lab samples 
Blood a 
1/1 
1/1 
0/1 
x 
• • • • 
. . . . 
1/1 . 
1/1 
• • • • 
1/1 
• • • • 
.... 
1/1 
1/1 
• • • • 
SIT 
resultsb 
+ 
+ 
w 
•••• 
y 
• • • • 
+ 
w 
• • • • 
+ 
+ 
+ 
+ 
Virus 
classi-
fication 
• ••• 
•••• 
• ••• 
•••• 
• ••• 
•••• 
•••• 
w Sewage line stoppage resulted in contamination of isolation cage. 
SIT repeated. 
~o blood sample. Spleen FATCT negative. 
YPig died 4 days after injection with specimen 112. No lesions of 
HC. SIT repeated. 
z 
From same suspected field case of HC as s pecimen 114. Pig injected 
with composite of inoculum prepared from specimens 114 and 120. 
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Tab le 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SJ:?leen Blood Blood3 result sh fication 
121 1/1 •••• 1/1 + 12 
122 1/1 •••• 1/1 + Ll 
123 0/2 • • • • . ... •••• 
124 0/1 • • • • 0/1 .... 
125 0/1 0/1 • • • • •••• 
126 2/2 2/2 1/1 + 12 
127 1/1 2/2 1/1 + ~ 
128 1/1 •••• 1/1 + 12 
129 0/1 0/1 • • • • •••• 
130 0/1 • • • • • ••• •••• 
131 0/1 0/1 • • • • •••• 
132 0/1 • • • • • ••• •••• 
133 0/1 • • • • 0/1 •••• 
134 1/1 •••• 1/1 + 12 
135 1/1 •••• 1/1 + 10f 
136 O/lc • • • • • • • • •••• 
137 1/1 •••• 1/1 + K.Mk 
138 1/1 .... 2/2 + 14 
139 1/1 1/1 1/1 + 11 
140 2/2 .... 1/1 + ~ 
141 1/1 1/1 1/1 + l01k 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blooda resultsb fication 
142 1/1 0/1 1/1 + 12 
143 2/2 1/2 1/1 DBn •••• 
•••• + 11 
144 0/2 0/2 • • • • •••• 
145 2/4 4/4 0/2 + Il 
146 1/1 1/1 1/1 + Il 
147 1/1 •••• 1/1 + L2 
148 1/1 1/1 1/1 + L2 
149 2/2 2/2 1/1 + L2 
150 1/1 1/1 1/1 + 12 
151 0/1 0/1 •••• • ••• 
152 1/1 •••• 1/1 + L2 
153 1/1 1/1 1/1 + 11 
154 Not examined d 1/1 + L2 
155 3/3c 3/3 1/1 + Ll 
156 0/1 0/1 •••• • ••• 
157 1/2 1/1 1/1 + Ll 
158 .... 1/1 1/1 • ••• 
0/1 +aa I2 
.... +aa I2 
aainjected with blood from pig injected with specimen 158. 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blood a resultsb fication 
159 1/1 0/1 1/1 + Ll 
160 1/1 •••• 1/1 + L2 
d e :_ 161 Not examined •••• Not examined 
162 2/2 1/2 1/1 + Il 
163 1/1 •••• 1/1 + L2 
164 1/1 1/1 1/1 + Ll 
165 0/4 •••• • • • • • ••• 
166 2/2 0/2 1/1 + L2 
167 0/1 0/1 •••• + 12 
• • • • • ••• 
O/lbb • • • • •••• 
168 2/2 •••• 1/1 + L2 
169 1/1 1/1 1/1 + Ll 
170 1/1 0/5 1/1 + L2 
171 l/lc 1/1 0/1 + 12 
172 1/1 1/1 1/2 DBn •••• 
•••• + L2 
173 1/1 0/1 1/2 + 12 
174 1/2 3/4 1/1 + Ll 
bb Pig killed 6 days after injection with specimen 16 7. Both 
blood and spleen FATCT negative. 
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Tab le 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number S:eleen Blood Blooda resultsh 
175 1/1 1/1 1/1 + Ll 
176 1/1 1/1 1/1 + Ll 
177 0/1 0/1 <. • • • • ·-... 
178 0/1 . . . . •••• • ••• 
179 2/2 •••• 1/1 + L2 
180 2/3 0/1 1/1 + L2 
181 2/2 0/1 0/1 + 12 
182 1/1 .... 1/1 + KJ< 
183 1/1 5/5 0/1 + 12 
184 1/1 0/1 1/1 + L2 
185 0/1 0/1 •••• • ••• 
186 1/3 1/3 0/1 + 12 
187 0/1 0/1 •••• • ••• 
188 Not d Not . de examined •••• examine 
189 0/2 0/4 •••• • ••• 
190 2/2c 2/2 1/1 + L2 
191 1/1 2/2 1/1 + L2 
192 2/2 3/5 1/1 + L2 
193 Not d examinede examined •••• Not 
194 1/1 2/2 1/1 + Ll 
195 1/2 0/2 1/1 + L2 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blood a resultsb fication 
196 2/2 0/2 1/1 + 11 
197 0/1 0/2 •• •• • ••• 
198 1/1 2/2 1/1 + 11 .:. 
199 2/2 2/2 1/1 + 11 
200 1/1 •••• 1/1 + 11 
201 0/2 0/1 . . . . •••• 
202 No t examined d 1/1 + Ll 
203 2/2 1/2 1/1 + 11 
204 2/2 0/1 1/1 + Ll 
205 2/2 2/2 1/1 + L2 
206 1/1 •••• 1/1 DBn 
12 
•••• + 12 
207 1/1 0/2 1/1 + 12 
208 5/5c 3/5 1/1 + Ll 
•••• + 11 
.... + 11 
209 1/1 .... 1/1 + 12 
210 2/2 2/2 1/1 + 11 
211 1/1 1/1 1/1 DBn •••• 
.... + 12 
212 3/3 1/1 1/1 + 12 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blooda resultsb fication 
213 0/1 0/2 1/1 + Ll 
•••• + 12 
214 3/3 3/3 1/1 + I 2 
215 0/1 0/2 • • • • •• •• 
216 2/2 0/1 1/1 + 12 
217 1/1 1/1 1/1 DBn •••• 
•• • • + 12 
218 0/1 0/1 • • • • •••• 
219 1/1 1/1 1/1 •••• 
•••• + 12 
220 1/1 0/1 1/1 DBn •••• 
•••• + 12 
221 2/2c 2/2 1/1 DBn •••• 
.... + 12 
222 2/2 3/3 0/1 DBn •••• 
•••• + I2 
223 1/1 •••• 1/1 + 11 
224 1/2 1/2 1/1 + L2 
225 1/1 1/1 1/1 + 11 
226 3/3 1/1 1/1 DBn •••• 
•••• + 12 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Fi e l d sampl es Lab samples SIT classi-
numbe r SEleen Blood Blood a r esultsb fi cation 
227 1/1 1/1 1/1 + 11 
228 1/1 .... 1/ 1 + 13 
229 2/2 1/2 1/1 + 11 
230 2/ 2 .... 1/1 DBn • ••• 
•••• + Ll 
231 .... 2/ 2 1/ 1 + 1 1 
232 1/1 0/4 0/1 + Il 
233 0/1 •••• 1/1 + 12 
.... + 12 
234 1/3 1/3 1/1 + 12 
235 1/1 . . . . 1/1 DBn •••• 
•••• + 11 
236 .... l/2c 1/1 + 12 
237 2/2 •••• 1/1 + 11 
.... + 12 
.... + 11 
238cc 1/1 3/3 . . . . • • • • •••• 
239 1/1 0/ 1 1/1 + 11 
240 1/2 .... 1/1 + I 2 
cc Fr om same suspected f i el d case of RC as specimen 231. No SIT 
done with t his speci men. 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number S2leen Blood Blood a resultsb fication 
241 1/1 •••• 1/1 + 12 
242 2/2 .... 1/1 + 12 
243 2/2 2/2 1/1 + 11 -
.... + 11 
•••• + 11 
244 5/5 1/1 1/i + 12 
245 0/2 0/2 •••• • ••• 
246 1/1 1/1 1/1 + 12 
247 1/1 •••• 1/1 + 12 
248 1/1 0/1 1/1 + 11 
- 11 249 2/2 2/2 1/1 + 
250 1/1 1/1 .... + 11 
251 1/1 •••• 1/1 + 11 
252 l/lc .... 1/1 + 11 
253 2/2 .... 1/1 + 11 
254 0/2 •••• . ... • ••• 
255 1/1 •••• 1/1 + 12 
256 1/1 1/1 1/1 + 11 
257 1/1 1/1 1/1 + 12 
258 1/1 2/4 1/1 + 12 
259 1/1 1/1 1/1 + 12 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number Spleen Blood Blood a resultsb fication 
260 1/1 1/1 1/1 + L3 
261 1/1 0/1 1/1 + 11 
262 2/2 2/2 1/1 + 12 .;. 
263 Not d examined 1/1 + Ll 
264 0/1 0/1 • • • • •••• 
265 1/1 0/1 1/1 + Ll 
266 0/1 0/1 • • • • •••• 
267 2/2 1/1 1/1 + 12 
268 1/1 1/1 1/1 + 12 
269 1/1 1/1 1/1 + Ll 
270 1/1 1/1 1/1 + Ll 
271dd 0/4 0/3 • • • • •••• 
272 Not examined • • • • •••• 
273 O/lc . . . . • • • • •••• 
274 1/1 • • • • 1/1 DBn •••• 
•••• + Ll 
275 1/1 •••• 1/1 + 11 
276 0/2 0/2 • • • • •••• 
277 0/2 0/2 • • • • •••• 
278 0/1 • • • • • • • • •••• 
ddF rom same suspected case of HC as specimen 266 . 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blood a r esultsb fication 
279 0/1 .... 1/1 + Ll 
0/1 DBn •••• 
. . . . . ... .... 
280 2/3 •••• 1/1 + L2 
281 1/1 0/1 1/1 + L2 
282 2/2 3/3 l/l + Ll 
• ••• + Ll 
•••• + L2 
283 1/1 1/1 1/1 + Ll 
284 2/2 2/2 1/1 + Ll 
285 1/1 .... 1/1 DBn • ••• 
•••• + L2 
286 l/lc •••• 1/1 + 13 
287 2/ 2 2/2 1/1 + L2 
288 0/ 1 •••• • ••• • ••• 
289 1/1 .... 0/1 + I2 
290 2/ 2 • ••• 1/1 + L2 
291 1/1 .... 1/1 + 12 
292 0/2 0/1 ' 1/1 + 12 
.... + 12 
293 1/1 0/1 1/1 + 12 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number Spleen Blood Blood a resultsb fication 
294 0/1 •••• . ... • ••• 
295 0/1 •••• . ... • ••• 
12 '"'-296 0/1 .... 1/1 + 
• • • • • ••• 
297 2/2 •••• • ••• + Ll 
298 0/2 •••• • ••• • ••• 
299 2/2 0/2 1/1 + 13 
300 1/1 0/1 2/2 •••• 
2/2 + 14 
1/4 +ee 12 
0/2 ee - •••• 
301 l/2c 1/2 1/1 + 12 
302 
d Not e Not examined •••• examined 
303 2/2 •••• 1/1 + Ll 
304 1/1 0/1 1/1 + 13 
305 2/2 1/2 1/1 + Ll 
306 1/1 •••• 1/1 + 12 
307 1/1 1/1 1/1 + 12 
308 2/2 0/1 1/1 + L2 
309 0/1 0/1 . . . . •••• 
ee Contact exposure. Not injected with specimen 300. Details 
presented in previous Tables 17 and 18. 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number SEleen Blood Blood a resultsb fication 
310 3/4 •••• 0/1 + 14 
311 4/4 3/4 0/1 + 12 
312 2/2 1/1 1/1 + 12 ~ 
313 1/1 .... 1/1 + 12 
314 1/1 1/1 0/1 + 12 
315 1/1 0/1 1/1 + 11 
316 2/2 1/1 0/1 + 12 
317 1/1 1/1 1/1 + 12 
318 1/1 1/1 1/1 + 12 
319 2/2 •••• 1/1 + 12 
320 1/1 •••• 1/1 + 12 
321 O/lc 0/1 •••• • ••• 
322 1/1 •••• 0/1 + 12 
323 2/2 .... 1/1 + I2 
324 1/2 •••• 1/1 + 12 
325 0/1 •••• . . . . • ••• 
326 0/1 0/1 •••• • ••• 
327 2/2 .... 0/1 + Ll 
328 1/1 1/1 0/1 + 12 
329 0/1 0/1 .... • ••• 
330 3/3 2/3 1/1 + 12 
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Table 26 (Continued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number Soleen Blood Blood a resultsb fication 
331 13/13 .... 1/1 • ••• 
2/2 + L4 
4/4 +ff L4 
<. 
2/2 +ff L3 
.... +ff L3 
332 1/1 .... 1/1 + 12 
333 2/3 0/1 1/1 + I l 
334 1/1 1/1 1/1 + 12 
335 1/1 1/1 + 12 
336 O/lc .... 1/1 + L3 
.... + 11 
.... + 12 
337 1/1 0/1 1/1 + 12 
338 0/1 0/1 . . . . .... 
339 0/1 . . . . •••• 
340 Not 
d Not . de examined •••• examine 
341 1/1 0/1 1/1 DBn •••• 
.... + 12 
ff Contact exposure . Not inj ected with specimen 331. Details 
presented in pr evious Tables 17 and 18. 
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Table 26 (Cont inued) 
FATCT results Virus 
Specimen Field samples Lab samples SIT classi-
number Spleen Blood Blooda resultsb fication 
342 1/1 1/1 0/1 .... 
.... + Il 
343 0/1 .. .. 1/1 + 12 
344 0/1 .... . ... . ... 
345 2/2 1/1 1/ 1 + L3 
... . + 12 
346 1/1 1/1 1/1 DBn •• •• 
.. .. + 11 
.... + 12 
347 2/2 .... 1/1 + 12 
348 4/4 1/4 1/1 + 14 
